Clinical Evidence Technologies and Patient Care by Burke, Marianne D.
University of Vermont
ScholarWorks @ UVM
Graduate College Dissertations and Theses Dissertations and Theses
2019
Clinical Evidence Technologies and Patient Care
Marianne D. Burke
University of Vermont
Follow this and additional works at: https://scholarworks.uvm.edu/graddis
Part of the Health and Medical Administration Commons, and the Library and Information
Science Commons
This Dissertation is brought to you for free and open access by the Dissertations and Theses at ScholarWorks @ UVM. It has been accepted for
inclusion in Graduate College Dissertations and Theses by an authorized administrator of ScholarWorks @ UVM. For more information, please contact
donna.omalley@uvm.edu.
Recommended Citation
Burke, Marianne D., "Clinical Evidence Technologies and Patient Care" (2019). Graduate College Dissertations and Theses. 1022.
https://scholarworks.uvm.edu/graddis/1022
  
 
 
CLINICAL EVIDENCE TECHNOLOGIES AND PATIENT CARE 
 
 
 
 
A Dissertation Presented 
 
 
by 
 
Marianne D. Burke 
 
to 
 
The Faculty of the Graduate College 
 
of 
 
The University of Vermont 
 
 
 
 
 
In Partial Fulfillment of the Requirements 
for the Degree of Doctor of Philosophy 
Specializing in Clinical and Translational Science 
 
 May, 2019 
 
 
 
Defense Date: March 18, 2019 
 Dissertation Examination Committee: 
 
Benjamin Littenberg, M.D., Advisor 
John King, M.D., Chairperson 
Julie Lin, M.D. 
Charles MacLean M.D. 
Cynthia J. Forehand, Ph.D., Dean of the Graduate College 
  
  
ABSTRACT 
 Clinical evidence technologies (CETs) are information sources derived from 
medical research literature that may assist health care providers in continued learning, 
decision-making, and patient care. Examples of CETs include: MEDLINE/PubMed and 
Cochrane Reviews, research journal literature, print and electronic medical texts, clinical 
topic summaries, guidelines, and interactive decision tools. Clinicians utilize CETs to 
find answers to questions that arise during patient care. However, it was unclear if CETs 
had a measurable impact on provider practice or patient outcomes.  
 
 A literature review identified twenty-two articles evaluating CETs’ impact. 
Study designs included surveys, observational studies, randomized controlled trials and 
quasi-experimental methods. The review revealed mixed evidence of CET impact on 
provider-level outcomes such as improved diagnoses and treatments, and on patient level 
outcomes such as length of hospital stay and mortality. Additional research was needed to 
determine whether certain CETs or CET types have impact on patient care outcomes in 
clinically targeted areas.  
 
 We conducted a cluster-randomized controlled trial (CRCT) to evaluate the 
effect of a dermatology-focused CET (VisualDx) when used by primary care providers. 
We found no difference in the patient skin disease outcomes of resolution of symptoms 
and return visits for the same problem in that trial. Thirty-two PCPs and 433 patients 
participated. In proportional hazards modelling adjusted for provider clusters, the time 
from index visit to skin problem resolution was similar in both groups (Hazard 
Ratio=0.92; 95% Confidence Interval (CI)=0.70, 1.21; P=0.54). Patient follow-up 
appointments did not differ significantly between groups (Odds Ratio=1.26; CI=0.94, 
1.70; P=0.29).  
 
 In a follow up mixed-methods study, we sought to understand why VisualDx did 
not make a difference. All CRCT provider participants were surveyed about their 
experience in the trial. VisualDx users (intervention arm) were interviewed about their 
experience using the CET. Ease of access and usefulness for patient communication 
facilitated successful use while irrelevant search results and use of other sources were 
barriers. Although PCPs reported benefits, they did not perceive the CET as useful often 
enough to motivate using it frequently or exclusively, thereby reducing the likelihood of 
it making a difference in the problem resolution and return appointment outcomes. 
  
 There was no difference in skin problem resolution or number of follow-up 
visits when PCPs used VisualDx. PCPs did not perceive VisualDx as “useful” often 
enough for to use it frequently, or exclusively, thereby reducing the likelihood of this 
CET making a difference in patient-level outcomes. 
 
  ii 
 
CITATIONS  
 
Material from this dissertation has been published in the following form: 
 
Burke M., Littenberg B.. (2019). Effect of a Clinical Evidence Technology on Patient 
Skin Disease Outcomes in Primary Care: A Cluster-randomized Controlled Trial. Journal 
of the Medical Library Association. 107 (2), 137-148.  
 
 
  iii 
ACKNOWLEDGEMENTS 
 
This work would not have been possible without the mentorship and generosity of 
Benjamin Littenberg, MD, who shared so much of his knowledge and time with me. 
Many thanks to Research Assistants, Anna Burke, Ayodelle LeBruin MD, Michael 
Minyetti BS, Kaitlyn Peper BS, Mary Swenson MLS, and Jae Vick MLS for careful 
execution of the research protocols, and Gary Atwood, MLS, for randomization and 
contact with provider subjects. I am indebted to the UVMMC Primary Care Providers 
and over 400 patients who participated in the clinical trial. 
 The Center for Clinical and Translational Science provided essential office space and 
telecommunications support for the research. The CTS faculty, staff, fellows, and 
graduate students who taught, encouraged, and shared their knowledge with me were my 
mainstays throughout the entire process. Thank you Alan Rubin, Amanda Kennedy, 
Connie van Eeghen, Charles MacLean, Sylvie Frisbie, Kairn Kelly, CROW fellows, and 
so many others. I appreciated the sabbatical leave and other support I received from the 
UVM Libraries and Dean Mara Saule.  Thanks to Jae Vick who provided editing and 
proof-reading assistance in all chapters. I appreciate the time, interest, and forbearance of 
my Committee: John King, Julie Lin, Charles MacLean, and Benjamin Littenberg. 
 
Thank you Will Massie for your steady presence and patience. 
 
 
  
  iv 
 
TABLE OF CONTENTS 
Page 
 
LIST OF TABLES ........................................................................................................ viii 
LIST OF FIGURES ........................................................................................................ ix 
 Effects of Clinical Evidence Technologies on Provider Practice and 
Patients: A Literature Review .......................................................................................... 1 
1.1 Abstract ................................................................................................................... 1 
1.2 Introduction............................................................................................................. 3 
1.2.1 Clinical Evidence Technologies Definition ....................................................... 4 
1.2.2 Provider-Level vs. Patient-Level Outcomes Definitions ................................... 5 
1.3 Objectives ............................................................................................................... 6 
1.4 Methods .................................................................................................................. 6 
1.4.1 Literature Search Methods ................................................................................. 6 
1.4.2 Study Selection .................................................................................................. 7 
1.4.3 Data Extraction and Analysis ............................................................................ 8 
1.5 Results .................................................................................................................... 8 
1.5.1 Provider-Reported Outcomes of CETs .............................................................. 9 
1.5.2 Provider Practice-Level Outcomes with Independent Measures ..................... 14 
1.5.3 Patient-Level Outcomes ................................................................................... 18 
1.6 Discussion ............................................................................................................. 23 
1.6.1 Evidence of Provider Practice Impact with CET Use ..................................... 23 
  v 
1.6.2 Evidence of CET Impact on Patient-Level Outcomes ..................................... 25 
1.6.3 Strengths and Limitations of the Review ......................................................... 27 
1.6.4 Implications ..................................................................................................... 28 
1.7 Conclusion: ........................................................................................................... 28 
1.8 Tables .................................................................................................................... 30 
1.9 References............................................................................................................. 35 
 Effect of a Clinical Evidence Technology on Patient Skin Disease 
Outcomes in Primary Care: A Cluster-Randomized Controlled Trial ........................... 40 
2.1 Abstract ................................................................................................................. 40 
2.2 Introduction........................................................................................................... 41 
2.3 Methods ................................................................................................................ 44 
2.3.1 Study Design, Model, and Setting ................................................................... 44 
2.3.2 Provider Subjects ............................................................................................. 45 
2.3.3 Patient Subjects ................................................................................................ 46 
2.3.4 Intervention ...................................................................................................... 47 
2.3.5 Measurements .................................................................................................. 47 
2.3.6 Data Collection ................................................................................................ 49 
2.3.7 Blinding ........................................................................................................... 49 
2.3.8 Analysis ........................................................................................................... 49 
2.4 Results .................................................................................................................. 50 
2.4.1 Problem Resolution ......................................................................................... 51 
2.4.2 Return Appointments ....................................................................................... 53 
2.5 Discussion ............................................................................................................. 54 
2.5.1 Strengths and Limitations ................................................................................ 58 
  vi 
2.5.2 Implications ..................................................................................................... 60 
2.6 Conclusion ............................................................................................................ 60 
2.7 References............................................................................................................. 60 
 Barriers and Facilitators to Using Clinical Evidence Technology in 
the Assessment of Skin Problems in Primary Care ....................................................... 64 
3.1 Abstract ................................................................................................................. 64 
3.2 Background ........................................................................................................... 65 
3.3 Previous Study ...................................................................................................... 66 
3.4 Objective ............................................................................................................... 66 
3.5 Study Design ......................................................................................................... 66 
3.6 Methods ................................................................................................................ 67 
3.6.1 Quantitative Data and Analysis ....................................................................... 68 
3.6.2 Qualitative Data and Analysis ......................................................................... 70 
3.7 Results .................................................................................................................. 71 
3.7.1 Quantitative Survey Results ............................................................................ 71 
3.7.2 Qualitative Interview Results .......................................................................... 74 
3.8 Discussion ............................................................................................................. 83 
3.8.1 Barriers ............................................................................................................ 83 
3.8.2 Facilitators and Benefits .................................................................................. 84 
3.8.3 Impact on Patient Management ....................................................................... 85 
3.8.4 Strengths and Limitations of this Study ........................................................... 85 
3.9 Conclusions .......................................................................................................... 86 
  vii 
3.10 References........................................................................................................... 87 
 
  
  viii 
LIST OF TABLES 
 
 
Table Page 
Table 1.1: Studies CET impacts with provider reported data ........................................... 30 
Table 1.2: Studies on impact of CETs on provider practice outcomes ............................. 32 
Table 1.3: Studies on impacts of CETs on patient-level outcomes .................................. 33 
Table 1.4: Twelve randomized controlled trials or quasi-experimental studies that 
evaluated an effect of CET interventions on provider practice or patient-level 
outcomes ........................................................................................................................... 34 
Table 2.1: Characteristics of primary care providers and patients.................................... 51 
Table 2.2: Problem resolution and return visit outcomes ................................................. 52 
Table 3.1: Characteristics of 21 post-trial survey participants ......................................... 71 
Table 3.2: Results for VisualDx frequency of use, ease of use, and usefulness 
comparing years in practice .............................................................................................. 73 
Table 3.3: Profile of active group survey and interview participants’ status during 
CRCT ................................................................................................................................ 74 
  ix 
LIST OF FIGURES 
 
 
Figures                                           Page 
Figure 2.1: Model of the cluster-randomized pragmatic design ....................................... 45 
Figure 2.2: Flow of participants through stages of the cluster-randomized 
controlled trial ................................................................................................................... 50 
Figure 2.3: Proportion of patients whose skin problems remained unresolved over 
time ................................................................................................................................... 52 
Figure 2.4: Return appointments for 433 skin patients by experimental group ................ 53 
Figure 3.1: Model of behavioral steps to use a CET for patient care ............................... 68 
Figure 3.2: Questions in post-trial surveys of trial participants ........................................ 69 
Figure 3.3: Semi-structured interviews outline ................................................................. 70 
 
  1 
 Effects of Clinical Evidence Technologies on Provider Practice 
and Patients: A Literature Review 
1.1 Abstract 
Background: Barriers to utilizing the evidence from research persist in health care. The 
influence of the evidence-based medicine model and the availability of multiple evidence 
source types may have reduced barriers to health care providers’ use of evidence sources 
and increased the possibility of their impact on clinical practice and patient care 
outcomes. 
Objective: To evaluate the impact of clinical evidence technologies on clinical practice 
and patient outcomes.  
Methods: Research evaluating a variety of clinical evidence technologies was identified 
through iterative searches in MEDLINE, Google Scholar, and reference lists. Studies 
involving clinical evidence technologies (CETs) and measuring an impact on clinician 
practice and patient outcomes were eligible for inclusion.  
Results: Four clinical evidence technology types were identified in 22 studies that 
investigated the impact of clinical evidence technologies on clinical practice and patient 
outcomes. Technology types included multiple CETs in combination, multiple CETs 
searched by an intermediary, single CETs, and education in CET use. No consistent 
pattern of results was found across the studies. Positive results were found in randomized 
controlled trials, quasi-experimental studies of single CETs, and observational studies 
utilizing large data sets. Other quasi-experimental and randomized trials were negative. 
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Discussion: Serious design flaws were noted in several studies. There is conflicting 
evidence that CETS either individually or collectively improve provider-level or patient-
level health care outcomes. 
Conclusion: There is mixed evidence supporting an association of CET use with 
improved patient care. Research with rigorous study designs is needed to determine the 
effect of clinical evidence technologies on clinical practice and patient-level outcomes.  
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1.2 Introduction   
The information needs and information seeking behaviors of clinicians are well 
documented. A 2007 literature review of 36 studies of clinical information needs of 
physicians covered literature from 1999-2005. The review summarized their reported 
information needs as diagnosis related questions 10-40%, treatment information 14 – 
60%, and drug therapy 15-60% of information needed [1]. A 2013 review of 24 peer-
reviewed studies on information needs and information-seeking behavior found similar 
proportions of need for diagnosis information, drug information, and general treatment 
information needs. The same review confirmed that clinicians utilize diverse information 
sources including databases, textbooks, journal articles, the internet, and technologies 
integrated within the electronic health record [2].These systematic reviews also support 
the notion that clinicians, especially primary care providers, seek information regularly to 
support patient care. Obstacles to answering clinical questions and information 
acquisition have been reported for decades. Poor technology access, lack of available 
information sources, lack of relevant evidence in chosen source, time constraints, and 
lack of institutional support are reported as reasons for clinicians’ failure to use evidence 
sources in patient care [3-6].  
 With the emergence of evidence sources that may reduce time and access 
barriers such as point-of-care clinical summaries, optimized citation databases, and open 
access journal literature, it is reasonable to consider if they have a positive impact on 
clinical practice and patient care outcomes. We sought to identify research on the impact 
of clinical evidence technologies (CETs) use to improve clinical practice and patient 
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outcomes, and to assess the quality and findings of the research identified.  
1.2.1 Clinical Evidence Technologies Definition 
 We use the term “clinical evidence technologies (CETs)” in this review to apply 
to information sources derived from the medical research literature that may assist health 
care providers in their continued learning, decision-making, and patient care. We define 
the term “evidence” as “Grounds for belief;…the available body of facts or information 
indicating whether a belief or proposition is true or valid” [7]. Evidence in this context 
emphasizes the medical/ scientific knowledge-base and the authority it is based upon. We 
use “technology” in the sense of the application of knowledge for practical purposes [7]. 
In recent decades, technology has been thought of as pertaining to electronic devices 
only, but any device with practical purpose is a technology, so we considered printed and 
electronic materials, content and citation databases, educational programs, and literature 
search interventions as technologies. 
 Other terms have been used in the health care literature for similar or 
overlapping health care related technologies. “Knowledge-based information” (KBI) is 
the term used by the Joint Commission on Accreditations of Health Organizations. The 
2018 Comprehensive Accreditation Manual for Hospitals standard (IM.03.01.01) requires 
that knowledge-based information resources be “available, current, and authoritative” [8]. 
The manual has described knowledge-based information as that “found in the clinical, 
scientific, and management literature” [9].  
 Examples of CETs include citation databases, such as MEDLINE/PUBMED and 
Cochrane reviews, the published research journal literature, print and electronic medical 
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texts, clinical topic summaries, and technologies that incorporate clinical reference topics 
with diagnostic tools. While some CETS, such as decision-support and point-of-care 
summaries, may be oriented toward patient care episodes, others have more diverse goals 
and uses such as promulgation of research, professional clinical education, and life-long 
learning. CETs may include use of a singles CET or multiple CETs in combination such 
as the variety of resources available from a hospital medical library or accessed from an 
institutional website. 
1.2.2 Provider-Practice Level vs. Patient-Level Outcomes Definitions 
 This review identifies the impact of CETs on health care outcomes at the 
provider practice and patient levels. Provider-level outcomes are the intermediate steps of 
management, i.e. diagnosis or treatment decisions, safety measures adopted, or the 
avoidance of adverse events [10].  
 Patient-level outcomes are those outcomes that are the result of care from the 
patient perspective including mortality, symptoms, health status, impact on activity, 
perceived benefit, and costs to the patient such as length of hospital stay and charges for 
care. [11].  
 Several literature reviews have focused on health information technologies in 
general in health care [12], medical librarian services [13], and clinical decision support 
systems [14], but none have focused on the spectrum of literature-derived CETs and their 
impact on provider practice and patient-level outcomes. Therefore, we sought to identify 
research evaluating CETs and to assess it for quality and validity of evidence of impact 
on clinical management and patients. 
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1.3 Objectives 
 This review aims to identify research studies and assess evidence on the impact 
of clinical evidence technologies, as used by clinicians, on clinical management and 
patient outcomes. The specific objectives are to identify and assess research on 1) the 
impact of use of CETs on provider management of patients and 2) the impact of CETs on 
patient-level outcomes.  
1.4 Methods 
 We identified peer-reviewed journal articles in which an impact of clinical 
evidence technologies on clinical management or patient outcomes was evaluated.  
1.4.1 Literature Search Methods 
 We searched MEDLINE/PubMed and Google Scholar for peer-reviewed articles 
encompassing the impact of knowledge-based information sources and services (CETs) 
on practice and patient outcomes. Two concepts were combined in the searches: 1) terms 
to identify clinical evidence technologies and 2) terms to identify impacts on patient care 
outcomes at the provider practice and patient levels.  
Subject headings or terms employed to retrieve the articles on clinical evidence 
technologies in MEDLINE included “Databases, Bibliographic”, or “Databases, Factual, 
or “Information Services” or “Library Services” or “Libraries, Medical” OR “Information 
Storage and Retrieval/utilization” or “Hospital Information Systems” or “Decision 
Support Systems, Clinical” 
Subject headings and terms employed to identify impacts on clinician level 
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practice outcomes and patient-level outcomes included: “Physician's Practice Patterns” or 
“Information-Seeking Behavior” or “Evidence-Based Medicine/Methods” or “Patient 
Care” or “Diagnostic Accuracy” or “Quality of Health Care”, or “Quality Assurance” or 
“Referral patterns” or “Guideline Adherence” or “Hospital Mortality” or “Length of 
Stay”, or “Referral” or “Treatment Outcomes”. 
Articles were also identified by manual review of reference lists of identified 
articles and literature reviews on related topics. Additional searches were conducted in 
MEDLINE and Google Scholar using terms that described articles identified in manual 
reviews. The subject terms “Outcomes and Process Assessment”, “Diagnostic Errors”, 
and “Patient Readmission” did not yield additional articles. 
1.4.2 Study Selection 
 We did not limit inclusion to a particular study design, such as randomized 
trials, but were open to various study designs, including surveys, observational, 
interrupted time series (before and after), randomized, cohort, case control, and 
comparative effectiveness studies. Data were obtained from provider or patient self-
report, patient records, and insurance claims if a practice or patient level outcome was 
measured. Studies with clinicians of any type, including physicians, nurses or trainees, 
who were involved in patient care, were included.  
 Articles were excluded if they 1) made no reference to a medical knowledge-
based or literature-derived evidence source or content, 2) focused on undergraduate 
medical students alone, (3) reported provider knowledge, attitude, behavior, or 
satisfaction outcomes only, or 4) presented no data measuring clinically-relevant 
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outcomes.  
1.4.3 Data Extraction and Analysis 
 Details from the studies were extracted and appraised by the first author. A 
second reviewer assisted with the appraisal of study designs, outcomes, and findings. We 
extracted the following data from each included article: 1) Study first author and date of 
publication, 2) Study design and method, 3) Participants and sample size, 4) Setting, 5) 
Data source, 6) CET(s) assessed, 7) Outcomes measured, and, 8) Findings. The author 
reviewed the articles and judged inclusion and exclusion based on the pre-set criteria. We 
planned a descriptive synthesis of the data extracted, rather than statistical analysis 
because of the expected heterogeneity of study designs, CETs, and outcomes measured in 
the reviewed articles.  
1.5 Results  
An initial MEDLINE literature search returned 72 articles that warranted abstract 
review or full reading to determine eligibility. Eleven articles from that search were 
retained and included in this review. Of the excluded articles, about one-third were 
excluded because they lacked provider or patient outcomes, one-third lacked an 
evaluation of a literature derived CET, and others reported no data on primary outcomes. 
Five were literature reviews whose reference lists were examined. The additional eleven 
included articles were identified through the reference lists of relevant articles and related 
literature reviews, keyword and natural language searches in Google Scholar, and the 
recommendation of colleagues. Twenty-two articles evaluating four CET types met all 
inclusion criteria, including: 
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• Two that assessed clinician use of multiple-evidence sources [15, 16];  
• Five that evaluated expert literature search services accessing multiple evidence 
sources [17-21]; 
• Two that assessed education in EBM methods (acquiring and appraising CET 
evidence) interventions [22, 23];  
• Nine studies of a single commercially published or researcher developed product 
[24-33]; and 
• Three studies that compared effectiveness of two CETs, or one CET and a 
decision support tool [34-36]. 
 Studies were further analyzed by outcome and data source categories including 
clinician-reported impact of CETs, impact of CETs on provider practice with independent 
data sources, and impact on patient-level outcomes also with independent data sources.  
1.5.1 Provider-Reported Outcomes of CETs  
 Nine studies measured clinician perception of the evidence retrieved from CETs 
on their practice. Study designs include large sample cross-sectional surveys, pre- and 
post- surveys, and randomized trials. Provider-level outcomes included diagnosis, and 
treatment impacts, perceived overall impact on patient care, and time saved. 
(See Table 1.1)  
 Multiple CETs Used by Clinicians  
 Two multi-site cross-sectional clinician surveys evaluated the impact of multiple 
medical library-provided CETs on patient care. Marshall et al, surveyed over 16,000 
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health care providers, including physicians, residents, advanced practice nurses and 
others, employed at 118 hospitals. Participants were asked to recall a recent patient care 
incident and to answer questions about how use of library provided information sources 
had (or had not) affected patient care in that event [15]. Seventy-five percent of the 
respondents indicated that patient care was definitely or probably handled differently due 
to an evidence source used. In addition, avoidance of patient misunderstanding was 
reported by 23%, and avoidance of additional tests by 19%. Misdiagnoses were avoided 
by 13%, and mortality avoided by 6% in the recalled incident.  
 Another cross-sectional multi-institutional study surveyed 328 health care 
providers, including 203 physicians, in four hospitals in Colorado and Missouri of 
varying size (Sievert, 2011) [16]. In that study, 87% of attending physicians, 91% of 
residents and physician assistants, and 67% of nurses reported they had changed 
management of a patient with use of library-sourced CETs. More than four-fifths of the 
physician sub-group confirmed decision (84%), changed advice to patients (36%), and at 
least 70% modified diagnosis, therapy, and tests ordered.  
 Multiple CETs Searched by Intermediary  
 Three studies evaluated the impact of multiple CETs on provider practice 
outcomes when an intermediary literature search by an expert (such as a medical 
librarian) was performed.  
 A randomized controlled trial by McGowan et al. (2008) compared the 
effectiveness of a search by a medical librarian consult service, called JIT (Just-in-Time), 
to primary care providers (PCPs) self-search for answers to their clinical questions. [17]. 
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PCPs’ queries were randomized to the librarian search or self-search when the physician 
posed a clinical question to the central service. The 88 participants presented 1,889 
queries and rated each query’s results. The utility of evidence found for clinical decision-
making and the time to complete the search were the outcomes measured. Twenty percent 
of librarian searches resulted in improved practice and decision-making, compared to 5% 
of physician self-searches. The librarian searches answered questions in an average of 
13.7 minutes compared to 20.3 minutes (95% CI 18.7, 21.86) for the self-search. In this 
study, evidence searches conducted by medical librarians produced more patient-care 
relevant results in less time compared to physician searches. When a question was 
randomized to provider self-search, the PCPs conducted searches for only 40% of the 
questions.  
 Mulvaney (2008) conducted a randomized controlled trial in which clinician 
consult requests from four inpatient services were randomly assigned to a Clinical 
Informatics Consult Service (CICS) staffed by trained clinical librarians, or no CICS 
service [18]. Impacts on clinician actions regarding diagnoses and treatments were 
measured. Different or new treatments resulted from 14.9% of requests to CICS consult 
vs. 4.8% with no CICS, (OR 8.2 95% CI 1.04, 64.0). There were no significant 
differences in diagnosis related actions. CICS librarians spent more time on the evidence 
search, and presentation, 4 hours average, compared to clinicians who spent an average of 
1.6 hours. Though the CICS service undoubtedly saved time of the physicians who did no 
search themselves, the length of time reported for searching and filtering the literature in 
both groups was remarkably long compared to the time measured in other studies, 
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possibly limiting the generalizability of this service model. Also, some clinicians 
requested a CICS consult but refused randomization. The search was conducted for them, 
but their results were excluded from analysis, possibly reducing the impact of the CICS 
intervention on urgent or complex cases. 
 A cross-over design study (Aitken, 2011) evaluated a librarian search and 
education intervention with 50 resident participants who rotated through the control and 
intervention groups [19]. A majority (74%) reported they changed treatment plan and 
36% changed diagnoses based on the mediated search information. Although described as 
a controlled trial, there were no baseline data on pre-intervention patient management 
with CETs reported. With no outcome comparison with the control group, the value of 
the outcomes reported with this sample size is limited.  
 Single CETs by Commercial Publisher or Institutional Developer  
 Five studies evaluated individual commercial publisher or institutionally 
developed CETs with provider-reported data. 
 In a study evaluating DynaMed, a clinical topics summary, Alper et al (2005) 
conducted a randomized controlled trial to determine the CETs effect on decisions and 
time to find answers compared to usual sources [24]. Physicians were randomized per 
question to use DynaMed or not. Among 46 PCPs, 54% found answers that changed 
clinical decisions with DynaMed compared to 23% without (P=0.05). Median search 
time was 4.7 minutes with DynaMed vs. 4.8 minutes with other sources (P=0.64). The 
first author was the original developer of DynaMed, which is now owned by the 
commercial publisher EBSCO Health. 
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 Another study evaluated Quick Clinical, an institutionally developed CET 
comprised of aggregated evidence sources with a single access point. In a 4 month trial of 
Quick Clinical, 74% of 227 participating PCPs in Australia reported improved patient 
care after using it an average of 10 times the first month [37]. After a year, usage 
frequency dropped to three uses per month and reported treatment effects declined [38].  
 Comparative Effectiveness of CETs  
 Three studies compared effectiveness of variations of clinical evidence 
technologies on practice outcomes. Grad and Pluye et al. compared practice outcomes of 
a knowledge-based CET called CIRT (Clinical Information Retrieval Technology) that 
included literature derived content, such as Cochrane reviews and InfoPoems (a clinical 
topic summary), to a decision-support tool that included calculators and prediction rules 
[35]. The calculator and reminder type tool was associated with practice improvement in 
participant surveys more often than the more literature-based CIRT, in 25% vs 12% of 
searches. When used together, 78% of links retrieved from both source types had a 
positive practice impact.  
 A study by Del Fiol et al. (2008), compared the effectiveness of two versions of 
the CET Micromedex in a randomized trial [36]. Both versions were accessed by means 
of “Infobuttons” within the electronic health record (EHR). The control version included 
links to the drug prescriber CET (Micromedex) as generally published, and the other 
provided specific links to topics and performed imbedded searches within the CET. There 
was no difference in clinical impact of each link type and no difference in time spent. 
Participants reported high positive clinical impact in all sessions (62%) in both types.  
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 Maviglia studied the use of drug medication information sources embedded in 
an EHR by providers at 18 outpatient clinics that were randomized to either Micromedex 
or Skolar MD, both commercially available drug information databases [34]. No 
difference was reported for decision changes between groups.  The CETs combined 
answered the query in 84% of searches and resulted in a patient care decision change in 
15% of searches.  
 In these provider-reported outcome studies, the overall impact of the 
information sources on provider decisions was generally positive and, in a few cases, 
statistically significant. Impacts on care management were reported by 75% or more of 
participants in cross-sectional and multi-CET search studies. There were smaller effect 
sizes, i.e. 20% impact on care, with intermediary search vs. about 5% impact with 
provider self-searches. The difference in impact between variations of similar 
information sources was generally not significant except compared to a calculator and 
reminder tool.  
1.5.2 Provider Practice-Level Outcomes with Independent Measures 
 Seven studies measured impacts on provider-level outcomes using independent 
data from patient records or judged by specialist review. (See Table 1.2) 
 Five studies evaluated single published CETs, and two studies evaluated an EBM 
methods education intervention. Study designs included before-and-after, and parallel 
comparisons. Provider outcomes included impact on decision-making, diagnosis impacts, 
medications and treatments prescribed, referrals or consults, and clinician time spent.  
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 Single CET Evaluations with Independent Data 
 King (2007) evaluated use of a Clinical Evidence module imbedded in a 
computerized-physician order entry (CPOE) system [28]. Pediatric inpatients diagnosed 
with bronchiolitis comprised the sample of 147 patients admitted in a 6 month period 
before, and 187 patients after implementation of the module. Entry of the bronchiolitis 
diagnosis in the CPOE prompted the appearance of the CET with relevant evidence. 
Primary outcomes measured were frequency of ordering antibiotics, bronchodilators, and 
steroids. Length of hospital stay was also measured. In the post-implementation period, 
22% of patients received antibiotics with the CET vs. 37% before, a relative decrease of 
37% (P= 0.016), in-line with the CET evidence. There were no differences in 
bronchodilators or steroids ordered and no difference in patient length of stay.  
 Barbieri (2015) evaluated VisualDx, an interactive diagnostic tool with images 
and topic summaries [39], for impact on dermatology consults requested for inpatients 
before and after the CET was implemented [33]. The number of consults requested per 
month, and the rate of increase in consults were measured. Post-implementation the 
absolute number of consults decreased non-significantly by median 4.6 per month 
(P=0.75), and the rate of consults increased at the rate of one consult per month in both 
periods (P=0.99). 
 Another evaluation of VisualDx measured inclusion of the correct final 
diagnosis in the differential diagnosis list for patients initially diagnosed with cellulitis in 
the emergency department (ED) by resident physicians with and without the CET. [26]. 
Records of 145 patients admitted to the ED in 2 hospitals were reviewed and, of those, 28 
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(25%) were deemed misdiagnosed. The correct diagnosis was included in the differential 
in 18 of 28 cases (64%) when VisualDx was used by a resident vs. correct diagnosis 
included in the differential in only 4 of 28 cases (14%) by the ED admitting team without 
VisualDx (P=0.003).  
 Evaluating a dermatology-relevant CET, Gulati assessed a skin cancer 
information and education toolkit for impact on referral rates by General Practitioners in 
England [31]. Over 20% of English general practitioners accessed the toolkit online 
through a national physicians’ website in a six month period after it was deployed and 
marketed. The toolkit included referral guidelines for suspected skin cancer. In the year 
after toolkit introduction, there was no difference in referrals made to dermatologists by 
GPs compared to the pre-toolkit year reported in a national referral database. Use of the 
toolkit did improve GP confidence in skin cancer diagnosis according to a survey of those 
who used it.  
 The fifth study evaluating a single CET examined UpToDate [40]. In this study 
by Shimizu, researchers reviewed charts of 100 patients seen by general practitioners in 
outpatient clinics of a Tokyo teaching hospital [32]. Of 100 patients, half were seen by 
general practitioners (GPs) with access to UpToDate and half were seen by GPs without 
access. Patient records were screened for correct diagnosis at the index visit to 
ambulatory care. Decision of correct or incorrect diagnosis was determined by two author 
investigators reviewing cases independently using an algorithm for error identification 
described by Singh (2007) [41]. They found a 2% error rate in the UpToDate group of 
patients, compared to the 25% error rate in the control group. It was unclear from the 
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article how the physicians were equipped or not with UpToDate, how they were enrolled 
in the study, and if the reviewers were blinded to the group allocation of physicians and 
patients. While this study had independent validation of practice improvement, it lacked 
information about randomization and blinding that limits confidence in its findings.  
 Education in EBM Methods  
 Education in evidence-based medicine methods includes training in retrieving 
evidence from medical research literature, appraising it for quality, and applying it with 
patients. Two studies assessed the impact of education in EBM methods on treatments 
and tests ordered. The model in both was that participants would retrieve and appraise 
evidence information from CETs to determine the best protocol. Straus et al. compared 
physician orders at a community hospital for treatments before and after the education 
[22]. After a seven-hour education session in EBM methods, resident physicians ordered 
significantly more treatments validated with evidence from randomized-controlled trials 
or meta-analysis evidence than before (42% pre- v.62% post; P=0.016).  
 Shuval et al compared PCP orders for tests and medications for certain 
conditions pre- and post- a standardized curriculum intervention of five sessions plus 
individualized practice site teaching [23]. The tests and treatment orders measured were 
controversial in that the best evidence from the CETs taught in the intervention 
recommended protocols that were infrequently followed. In this study, there was no 
statistical difference (increase) in the proportion of evidence-based tests, such as vision 
screening P=0.67), or medications, such as Lipitor (P=0.87), ordered after the education.  
 While the education interventions had conflicting results on the provider 
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outcomes, both were associated with improved knowledge and skills in evidence 
retrieval.  
In the studies of CETs evaluated for impact on provider-level outcomes with 
independent data sources, the findings were mixed. Four studies had positive results for 
the primary outcomes measured (King, David, Shimizu, and Straus) and three had 
negative, i.e., no difference, findings (Barbieri. Gulati, and Shuval).  
1.5.3 Patient-Level Outcomes  
 Seven studies evaluated CETs with patient-level outcome measures. Three 
evaluated expert intermediary searches of multiple CETs, and four evaluated single 
commercially published CETs. Study designs included two observational studies, one 
RCT, and five quasi-experimental study designs. Outcomes including length of stay, 
mortality, quality indicators, readmission rate, charges, and hospital costs. (See Table 
1.3) 
 Intermediary Evidence Search Impact 
  An intermediary evidence search conducted by an expert librarian or physician 
was the CET intervention in three studies with patient-level outcomes. In a case-control 
study by Banks (2007), 55 inpatient cases presented at Medicine morning report were 
matched with 136 controls from the previous five years of hospital admissions [42]. A 
medical librarian on the team conducted an evidence search on questions raised by 
physicians concerning the cases. Cases and controls were matched on age, primary 
diagnosis, and secondary diagnoses with up to 3 co-morbidities. Length of stay was 
reduced by an average of two days with the evidence search support (P=0.023). Total 
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charges for hospitalization were lower, but not significantly different (P=0.24), in the 
intervention group, with a median difference of $1,392 between groups. There was no 
difference in 30-day hospital readmission rate. It’s possible that events occurring outside 
the study influenced the findings. The control group was drawn from patients from 1 – 5 
years (2001 to 2006) prior to the cases. The downward trend of length of stay in U.S. 
hospitals, occurring at the time could have influenced the positive LOS effect. In that 
period AHRQ data appears to show that US national length of stay had declined among 
Medicare beneficiaries, between 2006 and 2015 [43].  
 Similarly, Esparza conducted a study (2013) on the effect of a medical librarian 
intermediary search on the patient outcomes of length of stay and 30-day readmission 
rates [21]. The intervention arm included 252 patients admitted and treated by the 
physician team with medical librarian support. The control arm included 1948 patients 
treated by a second physician team with no support. This non-randomized study had a 
parallel design, i.e. the intervention and control arms occurred concurrently, reducing the 
likelihood of secular events influencing the results. However, LOS and hospital 
readmission rates were actually higher in the intermediary search supported patients. LOS 
was two days higher (median 6 days vs. 4 (P<0.001). Thirty-day readmission rates were 
likewise higher, 19% of patients vs. 13%, P<0.001. The re-assignment of patient cases 
from the intervention team to the control team may have biased the results against the 
intervention. Patients admitted and treated by the intervention group who did not require 
an evidence search, were “flipped” to the control group. Since literature searches were 
usually requested for more complex cases, moving less complex cases to control may 
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have kept more serious cases in the intervention group leading to longer hospital stays 
and readmissions.  
 A third study by Izcovich (2011) evaluated the intermediary search of multiple 
CETs for questions arising from patient cases with a randomized controlled trial [20]. 
The mediated searcher in this study was an attending physician informatics specialist. 
Patients were randomly assigned to a search supported group or an unsupported group for 
6 months. Questions that arose in the intervention group patients were supported by an 
evidence search in available evidence sources. Compiled information was sent to all 
members of the intervention group team. Outcomes measured from patient record data 
included mortality or transfer to ICU, readmission, and length of hospital stay. There was 
a half-day difference in length of stay favoring control, but it was not statistically 
significant (P=0.24). There were no differences between groups in the other primary 
outcomes. In this study it appears that all cases stayed within the assigned intervention or 
control group on the intention to treat principle. 
 Single CET Evaluations with Patient Outcomes 
Four studies evaluated the association of single CETs with patient outcomes. UpToDate 
was evaluated in two observational studies [29, 30]. Others evaluated were DXplain [27] 
and Clinical Evidence [28] . Some of the Clinical Evidence (King) study findings were 
reported earlier in the provider-level results. The length of stay outcome in that study is 
also included here.  
 Two observational studies evaluated UpToDate by comparing patient outcomes 
at hospitals with the CET and without it. The earlier (2008) study by Bonis compared 
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outcomes in 424 hospitals that licensed UpToDate to 309 hospitals that did not license it 
between 2000 and 2006 [29]. Hospital outcome data was taken from the proprietary 
Thomson Top 100 Hospitals Survey database. Information on hospital licensees was 
supplied by UpToDate, Inc. In that study Length of Stay was reduced 0.18 days 
(P<0.001). Statistically significant differences were found for reduced complications 
(P=0.048) and AHRQ patient safety indicators (P<0.001). There was no difference in 
mortality between the hospital groups (P=0.34). Two authors of this research were 
employed by UpToDate, Inc. (Bonis and Rind) and two others (Pickens and Foster) were 
employed by Thomson Healthcare, the source of the hospital data and analysis. The study 
was funded entirely by UpToDate, Inc.  
 In the second observational study on UpToDate (Isaac et al, 2012) patient 
outcomes in hospitals with licenses to UpToDate were again compared to those without 
licenses [30]. Outcomes compared were risk-adjusted lengths of stay, mortality rates, and 
quality performance. Measures were derived from aggregate and individual hospital 
Medicare and Medicaid insurance claims data. An UpToDate license in a hospital was 
associated with shorter average length of stay compared to non-UpToDate hospitals (5.6 
days versus 5.7 days; P< 0.001). Among six conditions such as stroke or hip fracture the 
reduction of length of stay was 0.1 to 0.2 days (P<0.001) for each condition. Smaller 
community hospitals were associated with larger effect sizes than large teaching 
hospitals. This study was funded by UpToDate, Inc. also, but, according to the disclosure 
statement, the corporation “had no role on study design, input into analyses presented, or 
drafting or editing the manuscript.”  
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 Two other studies of individual CETs with patient outcomes include trials of 
DXplain, a decision support system developed at Massachusetts General Hospital, and 
the Clinical Evidence variant (BMJ Publishing) imbedded in the electronic medical 
record described earlier. These CETs had interactive elements depending on provider 
input, such as patient symptoms or lab values, characteristic of clinical decision support 
systems.  
 The DXplain trial conducted in 2001-2002, (published in 2010) compared total 
hospital charges, Medicare Part A charges, and LOS in diagnostically challenging cases 
admitted before and after implementation of the DXplain tool in a large U.S. teaching 
hospital [27]. In the intervention period, total charges averaged $1,281 less per patient, 
i.e., 10% lower in patients admitted in the DXplain period (95% C I 1.2% , 18.2%, 
P=0.006). Cost of service was $990 lower (P=0.001) per admission with intervention. 
Statistically significant reductions in Medicare Part A charges were also reported. The 
pre-implementation portion of the study was within one year in advance of the 
intervention period, arguably reducing the impact of secular events biasing the findings.  
 The Clinical Evidence study, described earlier for its provider-level outcomes, 
also measured length of stay [28]. There was no difference in length of hospital stay 
between groups in that study.  
  We did not identify additional research articles evaluating an effect of CETs on 
patient-level outcomes meeting the definition of this review. A systematic review [12] to 
identify of randomized trials to increase the use of electronic health information by health 
care practitioners to improve clinical practice and patient outcomes overlapped with 
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CETs studies as defined here. It found no randomized controlled trials with a positive 
effect of Health Information Technology on patient outcomes. That review was 
concerned with electronic health information in general and on various devices. It 
identified trials comparing information sources, including some CETs, for effectiveness 
relevant to health care.  
  In this review, 12 randomized controlled trials or quasi-experimental research 
studies directly evaluated an effect of CET(s) on provider practice or patient-level 
outcomes. Of these, eight had a positive result for CET impact, three made no difference 
on impact, and one had a significant negative effect. (See Table 1.4) 
 
1.6 Discussion  
 This review identified research evaluating the impact of clinical evidence 
technologies on provider practice and patient outcomes. Impacts on provider practice and 
patients were measured on four CET types in 22 studies using multiple study designs 
with provider-reported and independent data. In the discussion we synthesize the study 
results on comparable outcomes to evaluate the strength of evidence we have reviewed.  
1.6.1  Evidence of Provider Practice Impact with CET Use 
 There is some evidence of improved patient care with CET use in the provider-
reported outcomes studies and in the independent-measures studies. All of the provider-
reported data studies indicated perceived improvements in patient care with the 
individual or multiple CETs evaluated. With independent verification of provider practice 
improvement, the results were mixed. 
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 Patient Care Decisions and Time 
 Overall effectiveness of a CET for impact on patient care decisions and 
physician time saved was measured in three RCTs in which intervention and control 
groups were assigned, and participating PCPs evaluated results per question. All three 
studies found statistically significant positive rating for patient care impact reported in 
intervention assigned queries compared to the control queries (Alper, McGowan, and 
Mulvaney) 
 In terms of provider time saved, a practice improvement that could increase 
clinician productivity, the average time for the librarian search to answer the question 
was 13.7 min per question compared to 20.3 minutes with provider search in the 
McGowan study. In the DynaMed study, there was no difference in time providers spent 
searching with and without DynaMed. These RCTs employed randomization and 
provider report per question enhancing the validity of the clinician-report with immediate 
response rather than longer term recall. These studies were positive for improved practice 
outcomes but mixed on the provider time saved. Depending on institutional goals and 
funding, evidence searches by a librarian intermediary for complex patient cases may 
save provider time and produce better results.  
 Diagnosis, Treatments, Tests, and Referrals 
 The cross-sectional surveys of hospital clinicians by Marshall and Sievert 
provided a detailed look at the provider perceived practice improvements [15, 16]. A 
positive impact of CETs on diagnosis was reported by 25% and 71% of clinicians, on 
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patient care management by 75% and 88%, on tests ordered by 19% and 78% in Marshall 
and Sievert respectively.  
 In accord with the provider survey perceptions on those impacts, there were 
positive findings for diagnostic accuracy, treatments and tests ordered found in three 
studies with independent measures. Greater diagnostic accuracy was demonstrated with 
the clinical topic summary UpToDate [32]. Fewer antibiotics were prescribed for 
bronchiolitis with the CPOE-imbedded CET DXplain [28], and more evidence-based 
therapies were prescribed after education in evidence retrieval and CET use (Strauss) 
[22].  
 On the other hand, there was no difference in for evidence-based treatments and 
tests after another CET education intervention [23]. Likewise there was no significant 
difference in frequency of inpatient dermatology consults with the interactive diagnosis 
CET, VisualDx [33], and no difference in general practitioners’ referrals to 
dermatologists after introduction of a dermatology reference tool kit [31].  
1.6.2 Evidence of CET Impact on Patient-Level Outcomes 
 In the studies measuring the effect of CETs on patient-level outcomes, there 
were positive outcomes in two observational studies and one quasi-experimental study 
and “no difference” or worse findings in an RCT and two quasi-experimental comparison 
studies. Patient-level outcomes measured in these studies were: length of stay in hospital 
(LOS), mortality or transfer to ICU, hospital readmission, and costs and charges for care.  
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 Length of Stay 
 Six of the 7 studies with patient-level outcomes measured length of hospital stay 
(LOS). Of those, three found an improvement i.e. reduced length of stay for patients, and 
three resulted in no difference or worse outcomes. The two observational studies of the 
clinical topic summary UpToDate found reduced LOS equal to one-tenth to nearly two-
tenths of a day associated with hospitals that licensed the CET [29, 30]. The Banks case-
control trial found a reduction in LOS by a median of 2.0 days (P=0.023) associated with 
a librarian intermediary search. 
 Five other studies found no difference or worse LOS outcomes with the CET 
intervention. In the RCT on handling difficult patient questions with an informatics 
expert intermediary search, there was a non-significant half-day increase in LOS in the 
intervention patients [20]. In the Clinical Evidence study average LOS increased non-
significantly from 2.8 to 2.9 days with the intervention [28]. In the Esparza study, LOS 
increased significantly in the intervention group by two days [21].  
 Mortality  
 Of three studies that evaluated a CET with a mortality outcome, only one 
observational study found an association with decreased mortality (Isaac), the others 
(Bonis and Izcovich) did not.  
  Costs, Charges and Readmission 
 One study found a significant reduction of total charges and service costs 
associated with use of the DXplain, the interactive decision support CET. In the Esparza 
study, there was no reduction of costs, or 30-day readmission in the intervention patients.  
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1.6.3 Strengths and Limitations of the Review  
 This review included relevant studies that met inclusion requirements regardless 
of study design, even if they were flawed in some way. One flawed study design 
(Esparza) kept cases requiring a librarian search in the intervention group, while 
transferring cases not requiring a search to the control team. This method of group 
assignment all but insured that comparatively sicker, and complex cases remained in the 
intervention group, making the significantly negative result improbable. The positive 
result of two days reduction in LOS in the Banks study was flawed because of the 1-5 
year difference between in observations between the intervention cases vs. controls. For 
the LOS outcome, only the observational study of UpToDate retains a plausible 
association with the CET evaluated. While the two large observational studies of 
UpToDate made adjustments for differences between hospitals and patients, neither 
adjusted for the availability of other CETs or evidence sources that may have been 
present. That there were greater effect sizes in community hospitals than in the larger 
teaching hospitals in the Isaac study could be due to the greater array of CETs usually 
available in large settings.  
 In the Shimizu study on diagnostic accuracy with UpToDate, the lack of 
description concerning the recruitment of physician participants, how case selection was 
accomplished , and the blinding of the review panel are concerning. These omissions in 
procedures raise questions concerning bias and validity in that study. 
The CETs evaluated in this study were subject to change, making it difficult to 
generalize about their individual value. Specific CETs and services in every category 
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have changed or ceased to exist since the original research was published. This fact limits 
any generalization about a particular CET. 
A limitation of this review is that it may not include all relevant articles due to 
variations in search terms for evidence technologies and patient outcomes, and due to the 
iterative nature of the searches. 
1.6.4 Implications  
How might patient care be affected with use of high quality CETs? Elkin 
suggested that the mechanism of improved patient outcomes and reduced costs may be 
that use of the CET may broadens the differential diagnosis on first admission so that the 
determination of the correct diagnosis occurs sooner. A similar argument was put forth by 
David. It is possible that by following the behavioral steps of the evidence-based 
medicine model in practice, from asking clinical questions, through acquiring evidence, 
and applying evidence to patients, providers may improve provider practice and patient-
level  outcomes [44, 45], but the evidence for that is limited based on the literature. 
 Future research is warranted. The provider-reported experience with CETs and 
the positive outcomes of a few controlled and observational studies indicate that effects 
of CET use might be demonstrated in randomized hypothesis testing research. Study 
designs and outcome measurements would need to be carefully chosen to avoid errors 
that bias the study or mask true effects. 
1.7 Conclusion:  
There is mixed evidence supporting an association of CET use with improved 
provider and patient outcomes. Additional research with rigorous study designs, such as 
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randomized trials, and appropriate patient-level outcome measures may further elucidate 
impacts of CETs on patient care outcomes, particularly in clinically targeted area. 
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1.8 Tables 
Table 1.1: Studies on CET impacts with provider reported data  
Author and 
publication date 
Study design/methods  Data source(s) Participants/Sample  Setting CET(s) evaluated: Name (if 
any) 
Outcomes Measured Findings 
Aitken, 2011 Cross-over design; 
Residents rotated 
through intervention and 
control teams 
Post-intervention provider 
surveys; 6 month period.  
50 Internal medicine 
residents.  
Teaching 
hospital, 
Canada 
 Multiple evidence sources; 
intermediary librarian search 
and brief instruction.  
% Treatment decision 
change 
88% changed treatment 
with skills learned and 
74% changed treatment 
plan with mediated 
search. 
% Diagnosis decision 
change; 
44% changed diagnosis 
with skills, and 36% 
with librarian search. 
Alper, 2005 Randomized Controlled 
trial; Clinical question 
by provider randomized 
per question to 
DynaMed vs. usual 
sources  
Clinician survey per question 
asked 
 52 Primary care 
providers; 698 
clinical questions 
U.S. + 3 
hospitals in 3 
other countries 
Single CET; DynaMed  Questions answered that 
changed clinical decisions 
per participant  
54% of PCPs found 
answers that changed 
clinical decisions with 
DynaMed vs. 23% 
without DynaMed, and 
17% no decision 
difference P=0.05 
Duration of search Median search time 4.8 
min. vs. 4.9 min. 
P=0.64. 
Del Fiol, 2008 Controlled trial; 
comparative technology 
assessment; computer 
logs and survey 
Computer log sessions 
recorded, and questionnaire 
presented immediately post- 
session  
90 Clinicians in 
matched pairs; 3,729 
sessions 
U.S.  2 CETs; Micromedex versions 
in CPOE system Infobutton 
prompted 
Impact on decision- links to 
evidence by topics 
compared to links to named 
evidence sources 
35% of sessions in 
control group reported 
decision enhancement 
vs. 18 (38%) in topic 
enhanced group. 41 
(36%): no difference 
Grad, 2005 Comparative technology 
assessment; Impact of 2 
clinical information 
retrieval technologies; 
Providers surveyed per search 
session for impact of results;  
  
26 Family Medicine 
residents;4946 
searches  
Canada 2 CETs; CDSS with prediction 
rules and calculators vs CIRT, 
a CET with bibliographic 
database and topic summaries. 
Impact of each information 
item retrieved from each 
technology 
CDSS associated with 
practice improvement 
more 25% vs 12% CIRT  
Magrabi, 2004 Post-trial of CET 
survey; Oct.-Nov. 2002 
Computer log of usage per 
participant; participant survey 
based on recalled incident 
during trial.  
227 general 
practitioners; 
volunteers from 
across Australia 
Australia Single CET; Quick Clinical 
(QC), aggregated evidence 
sources optimized for clinical 
queries 
 Experience of 
improvement in care. 
25.6% (40) reported 
experience of QC 
resulting in improved 
patient care after using 
CET. With 6 or more 
uses, 50% reported 
improvement 
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Table 1.1 continued 
Author and 
publication date 
Study 
design/methods  
Data source(s) Participants/Sample  Setting CET(s) evaluated: Name (if 
any) 
Outcomes Measured Findings 
Marshall, 2013 Cross-sectional 
multi-site 
critical incident 
survey 
Survey responses 16,122 Physicians, 
nurses, and other 
healthcare providers; 
118 hospitals served by 
56 medical libraries 
U.S. Multiple CETs provided by 
medical libraries 
Impact on:  
Patient care 75% definitely or probably handled 
patient care differently; 
Patient advice 48% changed advice to patient 
Diagnosis 25% diagnosis change 
Drug choice 23% drug choice 
Additional tests 19% additional tests 
Medication errors 12% medication errors avoided 
Maviglia, 2006 Prospective 
cohort study; 
Comparative 
effectiveness of 
2 drug 
information 
technologies; 
randomized 
Primary care providers 
survey 
359 providers; 18 
outpatient clinics 
U.S. 2 CETs; Micromedex 
compared to Skolar MD 
Alteration of patient care 
decisions 
No difference in decision changes 
between groups; the 2 sources 
combined resulted in patient care 
decision change in 15% of searches.  
McGowan, 2008 Randomized, 
controlled 
study; 
randomized per 
question 
Search log and 
provider questionnaire: 
survey 
88 Primary care 
clinicians, 1889 
questions 
Canada Multiple CETs with rapid 
librarian search service: Just-
in-Time service  
Impact of search results on 
clinical decision 
20% of questions to librarian search 
had a high positive impact on care 
decisions vs. 5% of physician self-
searched questions 
Librarian search time 
compared to physician self-
search time 
Avg. librarian search 13.7 min (95% 
CI 13.3, 13.8) per question vs. 20.29 
min. (CI 18.7, 21.86) with provider 
search 
Mulvaney, 2008 Randomized 
controlled trial; 
Clinician 
consult request 
assigned to 
consult service 
or no consult 
service 
Post-consult request 
CLIC search clinician 
report and clinician 
self-search report. 
299 consults; 89 
clinicians from 4 
inpatient services  
Academic 
Medical 
Center, U.S. 
Multiple CETs with librarian 
search service: Clinical 
Informatics Consult Service 
(CICS)  
Actual impact on care; Different or new treatment 14.9% 
with CICs consult vs. 4.8% no CICS 
OR 8.2 (95%CI 1.04 -64.0). 
Specific impacts on 
clinician actions regarding 
diagnoses and treatments 
No difference in diagnosis related 
actions 
Sievert, 2013 Cross-sectional, 
multi-site 
survey 
Survey; recall in any 
incident. 
328 hospital providers 
and caregivers in 4 
hospitals including 203 
physicians  
4 hospitals 2 
states, US 
Multiple CETs; 
PubMed/Medline; MDConsult 
(electronic textbooks and 
journals) plus other Library 
provided sources 
Library CETs:  
Management impact 88% changed management of patient 
Decision confirmation 84% of physicians confirmed 
decision 
Advice to patient 84%; changed advice to patient 
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Table 1.2: Studies on impact of CETs on provider practice outcomes  
Author and 
publication date 
Study design/methods  Data source(s) Participants /Sample  Setting CET Source(s) Type: 
name (if any) 
Outcomes Measured Findings 
Barbieri, 2015 Interrupted time series; 12 
months before and 18 
months after VisualDx 
implementation 
Patient records; 
dermatology 
consults requested 
System-wide physicians 
and patients  
Academic Health 
care system; US 
Single CET: VisualDx  Absolute number of 
consults 
Absolute number of consults 
decreased by median 4.6, non-
significantly P=0.75 
Rate of increase in 
consults before v. rate of 
increase of consults after 
Consults increased at a rate of 1 
consult per month in both periods 
P=0.99 
David, 2011  Comparison of correct 
diagnoses in differential 
by physicians with 
VisualDx vs admitting ED 
physicians without it;  
Patient admission 
records; post-
admission review  
145 patients diagnosed 
with cellulitis in ED; 
Comparison on 28 
misdiagnosed cases  
2 teaching 
hospitals; U.S. 
California and 
New York 
Single CET: VisualDx Inclusion of the correct 
diagnosis in the 
differential diagnosis in 
misdiagnosed cases  
Correct diagnosis was included in 
differential with VisualDx (18/28 
64%) vs. the admitting team 
without Visual Dx had the correct 
diagnosis in 4/28 cases (14%) 
P=0.003 
Gulati, 2015 Observational; 
Comparison of national 
skin cancer referrals pre 
and post CET. 
Cross-sectional survey 
post-deployment of toolkit 
Health service 
referral database 
 
Survey 
General practitioners; 
20% of General 
practitioners in England 
accessed the toolkit in 6 
month period 2012 
England  Single CET: Skin cancer 
educational toolkit  
Number of skin cancer 
referrals 
No difference in referrals behavior 
in national database pre vs. post-
toolkit year 
 
Improved confidence in diagnosis 
King, 2007 Before and after evidence 
module implemented 
Hospital 
pharmacy and 
discharge records 
334 Pediatric inpatients 
with bronchiolitis 
diagnosis 147 pre- 187 
post year following 
intervention; resident 
physicians and medical 
student trainees  
Pediatric hospital, 
Ottawa Canada 
Single CET: Clinical 
Evidence Module  
% frequency of antibiotics 
prescribed  
Fewer antibiotics prescribed; 35% 
to 22%, relative decrease 37% P= 
0.016  
Bronchodilators and 
steroids prescribed 
No difference in bronchodilators 
and steroids 
Shimizu, 2017 Retrospective chart 
review comparison; 
"patients randomly 
selected" 
Patient records; 
initial diagnoses 
100 outpatients of GPs 
with and without 
UpToDate; "equipped vs. 
"non-equipped" GPs 
Ambulatory 
clinics of teaching 
hospital Tokyo, 
Japan 
Single CET: UpToDate  Diagnostic errors per 
group 
2%diagnostic error rate in exposure 
to UpToDate group vs 24% error 
rate in control. OR 15.2 (95% CI 
1.86, 124.4) 
Shuval, 2007 Controlled trial; Pre-Post 
evaluation of education;  
HMO patient 
database for 
controlled trial;  
Primary care clinics; 75 
PCPs and 106,349 patient 
records  
HMO clinics; 
Israel 
Education in EBM 
evidence retrieval and 
appraisal methods 
% adherence to evidence 
for tests ordered  
No statistical difference in 
evidence-based tests ordered such 
as eye examination (P=0.67) 
% adherence to evidence 
for drug utilization 
Patient drug utilization such as for 
statins (P=0.87) after intervention  
 
Straus, 2005 Pre-Post-intervention 
chart review of discharge 
summaries 
Patient discharge 
summaries 
47 physicians; 239 
patients pre-, 244 post  
Single site 
teaching hospital, 
UK 
Education in EBM 
evidence retrieval and 
appraisal methods 
Treatments ordered in line 
with available RCT or 
systematic review 
evidence 
Proportion of treatments supported 
by RCT or systematic review 
increased from pre- 49% to post-
intervention 62% (P=0.016) 
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Table 1.3: Studies on impacts of CETs on patient-level outcomes 
Author and 
publication 
date 
Study design/methods  Data source(s) Participants/sample  Setting CET Evaluated 
/Name(if any) 
Outcomes 
Measured 
Findings 
Banks, 2007 Case-control; prospective 
cases, retrospective controls 
Patient records  55 prospective inpatient cases 
to 136 matched retrospective 
controls seen by Medicine 
residents 
US, academic 
medical center 
Multiple CETs with 
intermediary search and 
filter by clinical medical 
librarian. 
Length of stay 
(LOS) (days) 
LOS reduced 2 days (P=0.023) 
Charges for 
hospitalization 
Total charges lower, median $1,392, 
non-significantly P=0.24 
30-day 
readmissions 
No difference in readmission rate 
Bonis, 2008 Observational study; 
Hospitals with and without 
CET compared; adjustment 
for size, region, and level of 
usage of the system 
Thompson Top 
100 Hospitals 
Study 
database; 
Publisher 
licensee 
identification.  
Medicare beneficiary 
inpatients at 3091 U.S. 
hospitals; 424 hospitals with 
UpToDate 
US Single CET/UpToDate LOS (days) LOS reduced 0.167 days (P<0.001) 
Complications Complications -0.378 P=0.048 
Patient safety 
indicators (AHRQ) 
Patient safety -0.08 P<0.001 
Mortality Mortality 0.179 P=0.34 
Elkin, 2010 Before and after 
implementation of evidence 
support tool; Residents used 
DXplain; Pt cases identified 
in DRG groups (all 
Medicare) 
Patient records Residents; Diagnostically 
challenging patients:1173 pre- 
period; 564 post- period 
Teaching 
hospital, Mayo 
Clinic, 
Rochester Minn. 
Single CET/DXplain  Total charges and 
cost of service for 
diagnostically 
challenging patients  
Total charges $1281 lower P=0.006. 
Medicare Part A charges $1032 lower 
P=.006; Cost of service $990 lower 
P=0.001 per admission in intervention 
(DXplain cases vs. control cases  
Esparza, 2013 Prospective matched cases. 
Data collection 78 weeks 
2008-9 
Patient records 2 physician teams; internal 
Medline service patients. 252 
cases, 1948 controls 
Urban Academic 
Medical Center 
US 
Multiple CETs with 
intermediary search and 
filter by clinical medical 
librarian  
LOS (days) LOS, higher median 6 vs. 4 P<0.001 
% 30-day 
readmission  
Readmission rates higher 19% vs. 13%, 
P<0.001 
Isaac, 2012 Observational study; 
Retrospective comparison 
of hospitals with vs. 
without CET. 
CMS Medicare 
data for US 
hospitals; 
publisher 
supplied 
license status. 
Fee-for-service Medicare 
beneficiaries. 3000 US 
hospitals; Medicare patients 
US Single CET/UpToDate Risk-adjusted LOS 
(days) 
LOS 5.6 vs. 5.7 days P=0.001 (CI -0.2, 
0.00) 
Mortality rates for 3 
conditions 
Mortality range -0.1% - 0.6% reduction 
Izcovich, 2011 RCT; patients randomly 
assigned to literature search 
support for provider 
questions vs. no support. 
Intention-to- treat analysis 
Patient records 809 patients admitted to 
Medicine ward 
Academic 
medical center, 
Argentina 
Multiple CETs with 
intermediary search and 
filter by informatics 
specialist. 
LOS (days)  LOS 6.5 v 6 days, 
Mortality or 
transfer to ICU,  
Mortality or ICU transfer RR 1.09 (95% 
CI 0.7, 1.6)  
Readmission Readmission RR 1.0 (95%CI 0.7, 1.3) 
King, 2007 Before and after evidence 
module implemented 
Patient records 334 pediatric inpatients with 
bronchiolitis diagnosis; 147 
pre-, 187 post- 
implementation. 
Pediatric 
hospital, Canada 
Clinical Evidence 
Module (BMJ Clinical 
Evidence) integrated 
with CPOE 
  
LOS (days)  
Median LOS increased 0.1 day post 
implementation P=0.125 ER through 
admission and discharge 
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Table 1.4: Twelve randomized controlled trials or quasi-experimental studies that evaluated an 
effect of CET interventions on provider practice or patient-level outcomes  
First author, 
year published 
Study design; 
sample size 
CET type and/or 
name  
Outcome(s) 
measured 
Effect (intervention 
v. control) or 
difference (+ = 
significant result) 
Alper, 2005 RCT; 52 PCPs, 698 
queries 
DynaMed % changed clinical 
decisions 
(+) 54% vs. 23% 
P=0.05 
Banks, 2007  Case control; 55 
inpatient cases to 136 
controls 
Multiple/Intermediary 
evidence search 
LOS (days) 
 
Hospital charges 
(+) 2 days lower 
(P=0.023); 
 
(-) $1,392 lower 
P=0.24,  
Barbieri, 2015 Interrupted time 
series; system-wide 
patients  
VisualDx Change per month in 
skin consults 
(-) 1 consult/mo. 
increase vs. same 
P=0.99 
Elkin, 2010  Before and after; 
1173 patients pre-, 
564 post-intervention 
DXplain  Total charges/pt.  
 
Cost of service/pt. 
(+) $1281 lower 
P=0.006. 
 
(+) $990 lower 
P=0.001 
Esparza, 2013 Prospective case-
control; 252 cases, 
1948 controls 
Multiple/Intermediary 
evidence search 
LOS (days)  
 
%Readmission to 
hospital 
(-) 6 vs. 4 P<0.001 
 
(-) 19% v. 13%, 
P<0.001, 
Izcovich, 2011  RCT; 809 patients Multiple/Intermediary 
search 
LOS (days) 
 
Mortality or ICU  
(-) 6.5 vs.6 P=0.25 
 
(-) RR 1.09 (95%CI 
0.7,1.6) 
King, 2007  Before and after; 334 
inpatients 
Clinical Evidence % antibiotics 
prescribed 
 
LOS (days)  
(+) 22% vs. 35%, P= 
0.016 
 
(-) Increased 0.1 day 
P=0.125 
McGowan, 
2008  
RCT; 88 PCPs, 1889 
queries 
Multiple/Intermediary 
search: JIT 
% queries with 
impact on care 
decisions 
(+) 20% vs. 5% P=NA 
Mulvaney, 2008  RCT; 89 physicians; 
299 consults 
Multiple/Intermediary 
search: CICS 
% different or new 
treatment 
(+) 14.9% vs. 4.8% 
OR 8.2 (95% CI 1.04, 
64.0).  
Shimizu, 2017  Parallel “with and 
without”; 100 
patients 
UpToDate % diagnostic errors  (+) 2% vs. 24% OR 
15.2 (95% CI 1.86, 
124.4) 
Shuval, 2007  Controlled trial; 75 
PCPs, 106,000 
patients 
Education in EBM 
methods 
% adherence to 
evidence for tests  
(-) no difference, 
P=0.67,  
Straus, 2005  Before and after; 47 
physicians, 483 
patients 
Education in EBM 
methods 
% adherence to 
evidence for 
treatment 
(+) 62% vs. 49% 
(P=0.016) 
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 Effect of a Clinical Evidence Technology on Patient Skin Disease 
Outcomes in Primary Care: A Cluster-Randomized Controlled Trial 
 
2.1 Abstract 
Objective: Providers’ use of clinical evidence technologies (CETs) improves their 
diagnosis and treatment decisions. Despite these benefits, few studies have evaluated the 
impact of CETs on patient outcomes. Investigators evaluated the effect of one CET, 
VisualDx, on skin problem outcomes in primary care.  
Methods: A cluster-randomized controlled pragmatic trial was conducted in outpatient 
clinics at an academic medical center in the Northeast. Participants were primary care 
providers (PCPs) and their adult patients seen for skin problems. The intervention was 
VisualDx as used by PCPs. Outcomes were patient-reported time from index clinic visit 
to problem resolution, and the number of follow-up visits to any provider for the same 
problem. PCPs randomly assigned to the intervention agreed to use VisualDx as their 
primary evidence source for skin problems. Control group PCPs agreed not to use 
VisualDx. Investigators collected outcome data from patients by phone at 30 day 
intervals. Cox proportional hazards models assessed time to resolution. Wilcoxon-rank 
sum tests and logistic regression compared need for return appointments. 
Results: Thirty-two PCPs and 433 patients participated. In proportional hazards 
modelling adjusted for provider clusters, the time from index visit to skin problem 
resolution was similar in both groups (Hazard Ratio=0.92; 95% Confidence Interval 
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(CI)=0.70, 1.21; P=0.54). Patient follow-up appointments did not differ significantly 
between groups (Odds Ratio=1.26; CI=0.94, 1.70; P=0.29).  
Conclusion: This pragmatic trial tested the effectiveness of VisualDx on patient-reported 
skin disease outcomes in a generalizable clinical setting. There was no difference in skin 
problem resolution or number of follow-up visits when PCPs used VisualDx. 
2.2 Introduction  
Health care providers across a spectrum of primary care and specialty domains 
regularly refer to clinical evidence technologies (CETs) to answer clinical questions [1]. 
As reported in provider survey and chart review studies, use of CETs such as 
PubMed/MEDLINE, journal articles, electronic texts, topic summaries, and internet 
search engines has improved diagnosis and treatment decisions and avoided adverse 
events [2-6]. Despite these provider reports, few studies have evaluated the impact of 
CETs on patient-level outcomes. Patient-level outcomes include mortality, relief of 
symptoms, impact on activity, perceived benefit, and costs to the patient such as length of 
hospital stay and lost work time [7]. The literature on patient outcomes of CET use is 
mixed. Only one published study has reported an improvement in patient outcomes. 
Researchers reviewed insurance claims from hospitals before and after subscribing to 
UpToDate (a source for comprehensive medical topic summaries). Results showed a 
modest reduction in morbidity and length of stay in hospitals after subscribing [8].  
 Hospital libraries and informatics centers acquire and make CETs available to 
the clinical community on the assumption that these resources have value for education, 
practice improvement, and the outcomes of care. CET licenses can be expensive. Medical 
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school libraries associated with teaching hospitals in the US or Canada spent an average 
of $US 2 million each in 2015 for medical research journals and clinical information 
resources [9].While CETs, individually or in combination, have been evaluated for 
education and practice-level outcomes, they have not undergone the rigorous evaluations 
with randomized trials for patient outcomes. A 2015 systematic review of electronic 
health information (EHI), including CETs, found no randomized trials with patient 
outcomes, such as relief from symptoms or utilization [10].  
  The broad nature and diverse goals of many CETs may discourage rigorous 
evaluation. However, skin conditions are a relatively circumscribed domain within the 
broad field of Primary Care. The clinical goal in many cases can be quantified as time to 
problem resolution. Likewise, the need for additional medical care after the index visit 
usually represents a suboptimal and expensive outcome that might be reduced by 
improved provider knowledge and decision support [11].  
Skin problems account for 15% of primary care office visits in the U.S [12] and 
ten common dermatologic conditions (dermatitis, pyoderma, tinea, benign neoplasms, 
candida, dermatosis, warts, malignant neoplasm, sebaceous cyst, and acne) account for 
77% of skin-related diagnoses in Family Practice. Likewise, many internal conditions 
manifest themselves on the skin, including malignancies, vascular conditions, anemia, 
endocrine disorders and pregnancy. Most skin conditions first present, and are often 
diagnosed and managed, in primary care. Eight percent of all outpatient visits for skin 
problems result in referrals to dermatologists or return visits to primary care [13]. 
Limitations in the ability of primary care providers (PCPs) to diagnose skin rashes and 
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lesions correctly have been noted in the literature [14, 15]. Some studies have indicated 
that additional dermatology knowledge, training, and diagnostic support could improve 
practice and patient outcomes. General Practitioners in the UK who used an online skin 
cancer diagnosis information source increased their diagnostic accuracy and confidence, 
but did not reduce referrals [16]. Referrals to Dermatology in a VA hospital that lacked a 
specific diagnosis were reduced by an intervention that trained PCPs. [17] 
VisualDx is a CET that presents images and text on a comprehensive range of 
skin conditions and symptoms whether they are local to the skin or are manifestations of 
internal conditions [18]. Users may search by diagnosis or by entering patient 
characteristics and examination findings to generate a differential diagnosis list with 
images. Individuals, practices, and institutions license VisualDx to support medical 
education and patient care [19]. VisualDx has been shown to improve diagnostic 
competency in non-primary care settings. In one study, its use improved the differential 
diagnosis of cellulitis by Emergency Room physicians [20]. In a pilot study, diagnostic 
accuracy of dermatology residents and medical students increased after using VisualDx 
as judged by a consultant dermatologist [21]. 
Given the prevalence and broad range of skin conditions seen in Primary Care, 
the need for improved knowledge and competency by PCPs in skin disease, the 
availability of a dermatology-focused CET (VisualDx) shown to affect clinical 
competence, and the lack of randomized clinical trials of any CET with patient-level 
outcomes, we proposed a clinical trial to evaluate use of VisualDx in Primary Care in the 
domain of skin disease with patient-level outcomes.  
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Our objective was to evaluate the effect of VisualDx on duration of symptoms 
and follow-up care for skin problems in a pragmatic randomized clinical trial in primary 
care. Recognizing that in typical clinical care, the correct diagnosis and therapy are often 
uncertain, that some problems resolve regardless of whether the management was 
technically correct, and that some resist even the most insightful management, we were 
concerned in this study with the net result of each episode of care – the patient outcomes 
– rather than the intermediate steps of management, i.e. diagnosis or treatment decisions.  
2.3 Methods  
2.3.1 Study Design, Model, and Setting 
We designed a cluster-randomized controlled trial (CRCT) to evaluate the 
outcomes of skin problems in patients whose PCP referred to VisualDx or not (usual 
care). In this design, PCPs were the subjects of randomization. Patients were clustered 
within the arm of the provider they saw for the skin problem. The cluster design was 
appropriate because the intervention is directed to physicians while the outcomes occur 
within individual patients [22]. With randomization, environmental and provider or 
subject characteristics (such as years in practice, insurance status, chronicity of the 
presenting complaint, comorbidities, etc.) are distributed at chance levels across both 
arms of the experiment. The model underlying the design of the experiment asserts that 
the CET supports the PCP in management (diagnosis, treatment, and referral decisions) 
and impacts patient-level outcomes, resolution of symptoms and return appointments, 
when used in a real-world clinical setting. Presumably, use of a valuable CET leads to 
more correct diagnoses and wiser therapeutic or referral choices. These, in turn, lead to 
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better patient outcomes (quicker resolution of the presenting problem or reduced need for 
additional care). To test this model, we performed a pragmatic [23], (i.e. not heavily 
controlled), cluster-randomized controlled trial of the impact of one CET on the 
outcomes of skin problems presenting to Primary Care  
 The study was conducted at clinics associated with an academic regional 
medical center in the Northeast. VisualDx and other CETs were available to medical 
center clinicians through the hospital Intranet, electronic health record (EHR), and mobile 
devices. The Institutional Review Board approved the protocol in June 2015.  
2.3.2 Provider Subjects 
Attending physicians, residents, advanced practice nurses, and physician 
assistants in outpatient Family Medicine and General Internal Medicine were invited to 
participate by email or personal contact. Eligible providers 1) were currently seeing 
patients at a Primary Care site, 2) consented and agreed to comply with the protocol 
Figure 2.1: Model of the cluster-randomized pragmatic design 
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procedures assigned, and, 3) permitted patients to be informed of the study via a letter 
sent over their signature. Providers answered a survey concerning resident/attending 
status, year of clinical degree, sex, specialty, and typical number of times per month they 
used CETs for patient care. (See Appendix I) 
We randomly assigned PCPs to intervention or control groups using a sequential 
numbered envelope method stratified by resident status [24]. We randomized residents 
independently because of the possibility that they respond differently to the intervention 
than more experienced providers. PCPs were enrolled in the study when they gave 
consent, completed the tutorial, provided their signature for patient letters, and reaffirmed 
their agreement to follow their assigned protocol.  
2.3.3 Patient Subjects 
Adult patients seen for acute or chronic skin problems, excluding lacerations or 
burns, were eligible. Patients were excluded if non-English speaking or decisionally 
impaired. To identify patients, investigators reviewed the appointment records of 
participating providers for patients seen for a skin problem. We identified patients with 
any complaint in the broad range of skin disease as noted in the EHR. The Reason for 
visit, Appointment note, and Clinical summary fields provided patient complaint 
information such as “rash”, “redness”, “lump”, “itch”, “wart”, “mole”, or “sore”. ICD 
codes were also used to identify potential cases. Per the institutionally-approved protocol, 
personal health information from the patient record such as reason for visit, phone 
number, and address could be used for identification and recruitment but not to ascertain 
patient characteristics or outcomes.  
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We sent each identified patient a letter signed by their PCP describing the study 
and informing them that the study team would call to invite their participation. The letter 
also stated how to opt out of any contact. 
2.3.4 Intervention 
The intervention was VisualDx as used by PCPs treating patients with skin 
problems. Providers received email notification of their experimental group status with a 
link to a self-paced slide tutorial specific to their group. (See Appendix II and III) For 
the Active group, the 5-10-minute tutorial included the direction to use VisualDx when 
needed in treating a patient skin problem, and how to access and use it. For Control 
providers, the tutorial included the direction not to use VisualDx, and a general 
orientation to information sources available through the Medical Library. A study team 
member contacted participating providers by email, phone, and letter at intervals during 
the study to remind them of their assigned protocol, and to re-confirm their continued 
participation. 
2.3.5 Measurements  
The primary predictor (independent variable) was the randomized group status 
of the provider: Active (use of VisualDx) or Control (non-use). Patient subjects were 
assigned to the group of the provider they saw. The primary outcome variables reported 
by the patients were: 1) time to resolution of the skin problem from presentation at the 
primary care office visit and 2) number of follow up visits (to any provider) for the same 
problem.  
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 About 30 days after the index visit, an investigator phoned each eligible patient 
(except those who had opted out) and, following verbal consent, proceeded with the 
interview questions. If the patient reported their presenting skin problem resolved, i.e. 
“All better”, their participation in the study was concluded. Patients whose presenting 
complaint had not resolved were re-interviewed at 60 days and, if still unresolved, again 
at 90 days. The 30-60-90 day phone call schedule was specified in the protocol to 
balance the requirements to reach many people while preserving patient recall [25]. 
 At the first interview, patients reported their age, sex, and whether the PCP seen was 
their usual provider (See Appendix IV).We ascertained the status of the skin problem as 
“All better”, “Improved,” Unchanged”, or “Worse”, each time we interviewed the patient. 
If “All better” at any interview, we asked them to recall the number of days from the 
index visit date or the date when they realized the problem was resolved. If necessary, we 
asked questions to aid more exact recall. This determined the “days to resolution” 
outcome data. If the problem was not resolved by the first interview, we interviewed the 
patients at 60 days, and if still not resolved, at 90 days. The final problem status at the 
last completed interview was determined for analysis. 
For the number of follow-up appointments, at the first interview, we asked how many 
appointments the patient had for the same problem since the index visit. If there was a 
second or third phone interview, we asked how many appointments they had since the 
last call and added that number to any previously reported appointments, if any. The total 
number of appointments reported comprised the variable.  
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2.3.6 Data Collection  
Trained research assistants using standardized scripts conducted patient 
interviews by telephone. Study data were collected and managed using REDCap 
(Research Electronic Data Capture) secure tools hosted by the researchers’ institution. 
2.3.7 Blinding  
By necessity, providers knew their own intervention or control group status. 
Investigators were blind to providers’ and patients’ group while conducting patient 
interviews. Patients were blind to the group assignment of their provider.  
2.3.8 Analysis 
We used Cox proportional hazards models to assess time to resolution and 
Wilcoxon-rank sum tests and logistic regression to compare return appointments between 
groups. Logistic and proportional hazards models were adjusted for clustering. Data 
analyses were performed using Stata 14 statistical software [24]. We sought an adequate 
sample size to detect a moderate-to-large effect of the intervention, on the order of 0.4 
standard deviations. Given the broad range of skin problems presenting in Primary Care, 
we expected significant variability in the time to resolution. Therefore, we chose a target 
of 8 days in time to resolution with a standard deviation of 20 days. The effect of 
clustering within PCP was not known, but we used estimates from other primary care 
settings that suggested an intra-cluster correlation of approximately 0.025 [20]. Assuming 
alpha=0.05, beta=0.80, 10 patients per provider, and a two-sided t-test, we estimated the 
study needed 26 PCPs and 260 patients.  
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2.4 Results 
 We enrolled 31 physicians and 1 nurse practitioner. We identified 989 eligible 
patients with a skin problem visit to a participating PCP between November 2015 and 
August 2016. 433 patients consented and provided data. 
The active and control groups were similar at baseline except for the median number of 
subjects per PCP (6 in the active group vs. 15 in the control group; P=0.045). Seven PCPs 
(22%) reported use of VisualDx prior to the study including 4 (27%) in the Control group 
who agreed not to use it during the trial.  
Figure 2.2: Flow of participants through stages of the cluster-randomized controlled trial 
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Table 2.1: Characteristics of primary care providers and patients 
  All Active Control P* 
Primary Care Providers, n  32 17 15  
 Residents  13 (41%) 8 (47%) 5 (33%) 0.43 
 Sex (male) 17 (53%) 10 (59%) 7 (47%) 0.49 
 Family Medicine (vs. Internal 
Medicine) 
14 (45%) 6 (35%) 8 (53%) 0.30 
 Year graduated, median 
(range)  
2010 2012 2002  0.44 
 (1976-2015) 
(1976-
2015) 
(1977-
2015) 
 
 Study patients per provider, 
median (range) 
13.5 (1-34) 6 (1-32) 15 (1-34) 0.045 
 Used any CET>10 times prior 
month 
27 (84%) 13 (77%) 14 (93%) 0.19 
 Used VisualDx prior month 
(yes) 
7 (22%) 3 (18%) 4 (27%) 0.54 
     
Patients, n  433 158 275  
 Age in years, median (range), 
431 obs. 
58 (19-94) 58 (20-91) 58 (19-94) 0.73 
 Sex (male), 431 obs. 214 (49%) 77 (49%) 137 (50%) 0.54 
 Completed all protocol 
interviews 
360 (83%) 126 (80%) 234 (85%) 0.15 
Unless noted, all cells contain n and (%). *P-value comparing Active and Control groups from 
Χ2 tests for categorical variables (proportions) and Wilcoxon Rank-Sum tests for ordinal and 
continuous variables. 
 
2.4.1 Problem Resolution 
48% of all patients in the study considered their skin problem resolved (“All 
better”) by the final contact, including 46% in the active group and 49% in the control 
group (P=0.48). Active and control patients were similar in terms of whether they were 
“All better”, “Improved”, “Unchanged” or “Worse” at their final interview (P=0.88).  
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Table 2.2: Problem resolution and return visit outcomes 
  All subjects  Active Control P* 
Patients, n  433 158 275  
Final skin status    0.88 
Resolved 207 (48%) 72 (46%) 135 (49%)  
Improved 104 (24%) 41 (26%) 63 (23%)  
Unchanged 108 (25%) 40 (25%) 68 (25%)  
Worse 14 (3%) 5 (3%) 9 (3%)  
Return visits     
Return visits per patient, 
mean (standard deviation) 
0.59 (1.07) 0.65 (1.10) 0.55 (1.05) 0.19 
Any return visits (vs. none) 148 (34%) 59 (37%) 89 (32%) 0.29 
Unless noted, all cells contain n and (%). *P-value comparing Active and Control groups from Χ2 tests 
for categorical variables (proportions) and Wilcoxon Rank-Sum test for number of visits. 
Time to resolution was similar in the two groups throughout the observation period of up 
to 120 days (P=0.56 by log-rank test).  
 
 
 
Figure 2.3: Proportion of patients whose skin problems remained unresolved over time 
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In univariable Cox proportional hazards modelling, with standard errors adjusted 
for provider clusters, the days from index visit to resolution were similar in both groups 
(Hazard Ratio (HR)=0.92; 95% Confidence Interval (CI)=0.70, 1.21; P =0.54). Tests for 
potential confounding by patient age and sex, PCP status (as resident and as patient’s 
regular provider), PCP time since graduation, number of subjects per provider, and time 
of the year, indicated no potential confounding. Therefore, these variables were not 
included in the analysis.  
2.4.2 Return Appointments 
Active group patients had a mean of 0.65 return appointments compared to 0.55 
in the control group (P=0.19). The median was 0 return appointments in both groups. 
Figure 2.4: Return appointments for 433 skin patients by experimental group 
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Thirty-seven percent of active patients had one or more follow-up appointments for the 
index problem vs. 32 % of control, P=0.29. 
When analyzed as a binary variable (any follow-up visits vs. none) in cluster-
adjusted logistic regression, the odds of a return visit in active group patients were higher 
than in the control group (Odds Ratio (OR) =1.25; CI =0.93, 1.67; P=0.15) but were not 
statistically significant. Tests for potential confounding by patient characteristics (age and 
sex), PCP characteristics (as resident, as patient’s regular provider, and time since 
graduation) or time of the year indicated no confounding. Therefore, these variables were 
not included in the model. However, the number of patients per provider was associated 
with both the use of any follow-up visits (P=0.066) and group assignment (P=.065) 
raising the possibility of confounding and was included in the final logistic regression 
model. The odds of any follow-up visits remained higher in the active group than the 
control group when adjusting for clustering and the number of subjects per provider 
(OR=1.14; CI=0.84, 1.56; P=0.39), but was not statistically significant. The intra-cluster 
correlation coefficient for both outcome measures was <0.00001 with an upper 95% 
confidence limit of 0.039. 
2.5 Discussion 
Patients with skin problems whose PCPs used the CET VisualDx experienced 
similar rates of problem resolution and similar time to resolution as patients whose 
providers did not use it. There was no difference in the number of follow-up visits to any 
health-care provider for the index skin problem.  
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The goal of this study was to assess effectiveness of a CET as used in a 
generalizable clinical setting, rather than to determine its mechanism of action or efficacy 
under ideal conditions. Therefore, we designed a “pragmatic trial” in a clinical 
environment in which day-to-day factors were not highly controlled. Pragmatic trials seek 
to answer the question “Does this intervention work under usual conditions?” [23]. 
Intervention PCPs had flexibility in how they followed their assigned protocol to 
reference VisualDx when a patient care uncertainty arose. They could have searched 
within VisualDx by diagnosis terms, as opposed to using the differential diagnosis 
support tool. They could also decide that assistance was not needed with some patients 
and opt not to employ the CET. They could seek advice from additional sources after 
consulting VisualDx.  
We obtained data for the primary outcomes from patient reports because we 
sought to understand the outcomes of care as the patients experienced it. Patient-reported 
outcome measures complement other health care indicators such as provider-reported 
outcomes, chart review, and insurance data. They are appropriate measures in research 
when the intervention is incorporated into treatment [26, 27]. They are frequently used in 
clinical trials of medical products, drugs, and in health-related quality of life studies [28].  
We did not evaluate whether the diagnosis or treatment decided upon by the PCP was 
correct by an objective standard, such as expert dermatologist review. Likewise, we did 
not distinguish appropriate follow-up appointments or referrals from unnecessary or 
avoidable ones, recording only that a follow-up occurred.  
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Physician-reported benefits of referring to CETs, such as correct diagnosis, 
treatment, and avoidance of adverse events have been noted previously. Marshall et al. in 
multi-institutional survey of physicians (n=4,906) and residents (n=1,290) in 118 
hospitals, found that 36% of physicians and 42% of residents changed a diagnosis after 
referring to a clinical evidence source in a recent recalled incident. Physicians (29%) and 
residents (32%) also reported avoidance of unnecessary procedures or tests because of the 
information they used in the incident [5]. 
Likewise, use of VisualDx may improve diagnostic skills. A team including the 
developer of VisualDx reported that among 28 cases initially misdiagnosed as cellulitis in 
the Emergency Room, VisualDx included the correct diagnosis in its differential 
diagnosis list more often than the admitting medical resident (64% vs. 14%; P=0.003). In 
a pilot study by Chou, clinical diagnoses of 13 patients were made by 13 dermatology 
residents and 51 medical students before and after using VisualDx. Diagnostic accuracy 
increased from 63% to 81% (P <0.01) as judged by a consultant dermatologist [23]. 
Despite these positive intermediate effects, the published literature, including the study 
reported here, provides no evidence of better patient outcomes.  
Why did use of VisualDx, a technologically sophisticated, well-designed, state-
of-the-art CET, fail to influence the tested outcomes for skin disease? Some potential 
reasons for the negative results in this trial, such as bias due to uneven distribution of 
patient or provider characteristics, were minimized by the randomized design of the 
study. Another reason we found no difference between groups could be that the VisualDx 
users had insufficient knowledge of the resource to use it effectively. However, active 
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group PCPs were made aware of the resource, what it was meant to do, and how to access 
it. They received more training on its features, via an online tutorial, than is usually 
available in clinical practice. Although the VisualDx interface appears intuitive and easy 
to use compared to other CETs (PubMed/MEDLINE for example), it is possible that 
PCPs found it difficult to find the information they needed. The specific content and 
interactive diagnosis tool of VisualDx, written largely by specialists, could be too 
complex or time-consuming in the Primary Care setting. This may have contributed to 
busy clinicians bypassing VisualDx at times, resulting in suboptimal management.  
Even if the content acquired by the PCPs was correct from a biomedical point-
of-view, the PCPs were not obligated to follow it. Indeed, local availability of certain 
procedures, prescriptions, and specialty referrals may make it unreasonable or impractical 
to follow the advice of the CET, leading to the “no difference” result.  
Finally, it is possible that many skin problems presenting in Primary Care are 
inherently resistant to improvement no matter how well-managed. They will resolve (or 
not) at their own pace regardless of the diagnosis and therapy offered. Nonetheless, one 
supposes that return appointments and referrals to dermatology could be reduced with 
optimal Primary Care management. 
This study tested the effectiveness of VisualDx for problem resolution and 
return visit frequency, not for other outcomes such as improved diagnosis, or satisfaction 
with care. This was not a comprehensive multi-attribute assessment of the CET. 
Likewise, ease of use and usefulness were also beyond the scope of this evaluation. 
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VisualDx is costly, and this study may help health care organizations determine whether 
that cost is appropriate for their local institutional goals and settings. 
2.5.1 Strengths and Limitations 
 The cluster-randomized parallel design reduced the likelihood of bias due to 
differences in the provider and patient subjects. Secular events occurring outside the 
study, such as seasonal changes in skin-related appointments, affected providers and 
patients in the intervention and control groups equally because of the randomized, 
parallel design. 
The study took place in one large academic medical center, possibly reducing 
generalizability to other settings. However, the patients of the study institution are similar 
to populations in rural regions of the United States in terms of age, race, poverty rates and 
other factors.  
Although this is the largest randomized study of a CET with patient outcomes to 
date, the power to detect a potential effect was limited. Given the sample size of 433 
patients, a control resolution rate of 49% within 90 days, and assuming α=0.05, the study 
had 80% power to detect a resolution rate of at least 63% in the active group using Chi-
square analysis. The observed rate was 46% and therefore not significantly different from 
control. In the Cox model, the observed Hazard Ratio of 0.92 (favoring control) was well 
under the minimum detectable HR of 1.24. Likewise, the study had 80% power to detect 
a difference of 0.30 return visits per patient. The observed rate was 0.10 higher in the 
Active group. Given that all analyses showed a trend towards worse outcomes, i.e. longer 
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time to resolution and more return visits in the Active Group, it highly unlikely that a 
larger study would have demonstrated a statistically significant beneficial effect.  
The study relied on provider adherence to the protocol based on their agreement to do so 
(which was confirmed periodically). We did not have independent confirmation of their 
adherence. There may also have been contamination between provider subjects since 
there were both active and control providers in some clinics. While the active group PCPs 
used VisualDx as their primary resource for skin-related uncertainty and the control 
group did not, both groups could use other CETs and resources available in the 
information-rich environment of the academic medical center. This access could have 
masked a positive effect of using VisualDx.  
We had limited ability to independently measure participant usage of VisualDx prior 
to the study. However, at baseline, 22% of PCPs reported use of VisualDx in a prior 
month with no significant difference between groups. We did not measure VisualDx use 
during the study. Nevertheless, we did encourage provider adherence to the protocol. 
When contacted, all providers confirmed they were staying within their assigned 
protocol, to use VisualDx as a reference or not.  
  The study relied upon the memory of patients which could have been faulty. 
However, the first patient interviews followed the index visit by approximately thirty 
days, a relatively short time span [25]. Only one patient who consented could not 
remember the skin problem visit at all.  
This study included patients with acute and chronic conditions reflecting the 
usual variety of skin conditions seen in primary care. It is possible that a study of only 
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acute skin conditions, or a study in an inpatient setting, might have had a different 
outcome.  
2.5.2 Implications 
While this CET did not make a difference in the patient outcomes studied, it 
may have value for other goals such as medical knowledge, decision confirmation, and 
diagnostic confidence. The pragmatic study design with patient-level outcomes proved to 
be feasible, and could be extended to evaluate other clinical evidence source technologies 
relevant to health care.  
2.6 Conclusion 
The study showed no difference in resolution of symptoms and return visits in 
patients of doctors who referenced VisualDx. Although VisualDx and other CETs may 
support institutional missions of medical knowledge and practice improvement, VisualDx 
does not appear to improve patient outcomes for skin problems managed in Primary Care.  
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 Barriers and Facilitators to Using Clinical Evidence Technology 
in the Assessment of Skin Problems in Primary Care 
3.1 Abstract 
Background: A previous cluster-randomized controlled trial tested the effectiveness of a 
clinical evidence technology (CET), VisualDx, for skin problems seen by primary care 
providers (PCPs). Based on patient report, there was no effect on time to problem 
resolution or return appointments. 
Objective: The objective of this investigation was to explain, from the provider 
perspective, why the CET did not make a difference in the clinical trial and to identify 
barriers and facilitators to successful use of VisualDx. 
Methods: We used a mixed methods study design. Providers from both arms completed a 
survey about their use of VisualDx and information-seeking during and after the trial. 
Active arm providers participated in interviews to explore their opinions and experiences 
using VisualDx. Behavioral steps of the evidence-based medicine (EBM) paradigm 
framed the analyses. The survey and interviews were conducted concurrently. 
Results: PCPs found VisualDx easy to use (median 3 on a 1-4 scale), but found it only 
somewhat useful (median 2 on a 1-4 scale). PCPs with fewer years in practice used it 
more often and found it easier to use. Interviews identified facilitators and barriers to 
using VisualDx. Facilitators included diagnostic uncertainty, positive attitude, ease of 
access, utility for diagnosis and therapy decisions, and utility for patient communication. 
Barriers included PCP confidence in dermatology, preference for other sources, interface 
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difficulty, and retrieval of irrelevant diagnoses and images. Some PCPs reported positive 
impacts on patient treatment and fewer referrals; others saw no difference. 
PCPs found VisualDx easy to access, but some found the interface difficult to use. They 
found it useful and relevant at times, but also frustrating and time-consuming. They used 
other sources in addition to, or instead of, VisualDx. 
Conclusion: PCPs did not perceive VisualDx as “useful” often enough for them to use it 
frequently or exclusively, thereby reducing the likelihood of it making a difference in 
patient-level outcomes such as problem resolution and return appointments.  
3.2 Background 
  Studies show that clinicians who use clinical evidence technologies (CETs) to 
answer clinical questions perceive that they change or confirm diagnoses and treatment 
decisions, avoid medical errors, and improve their practice [1-3]. Obstacles to answering 
clinical questions and information acquisition with CETs are also reported. Poor 
technology access, lack of available evidence sources, lack of relevant evidence in chosen 
source, time constraints, and lack of institutional support are described as reasons for 
clinicians’ failure to use CETs in patient care [4-6].  
  Evidence-based medicine (EBM), defined as “the integration of best research 
evidence with clinical expertise and patient values [7]” endorses the use of research-
based evidence found in medical journals, databases, and clinical topic summaries. In 
practice, EBM outlines basic steps that clinicians must take to effectively find and apply 
evidence. These steps may need to be executed quickly, often in a patient visit. The 
behavioral steps outlined for EBM in practice are 1) Ask a clinical question, 2) Acquire 
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available evidence, 3) Appraise and interpret it, and 4) Apply evidence with patient 
values and preferences [8, 9]. 
3.3 Previous Study 
 VisualDx is a factual knowledge database and diagnostic tool that matches 
patient symptoms with images to suggest likely diagnoses and management strategies 
[10]. Research suggests that its use improved ER physicians’ knowledge and accuracy of 
diagnosis for cellulitis [11], and diagnoses by dermatology residents and medical students 
for other skin conditions [11, 12].  
  Use of VisualDx, a CET, by primary care providers (PCPs) was the intervention 
in a 2016 cluster-randomized controlled trial (CRCT) [13]. In the CRCT, PCPs were 
randomly assigned to use VisualDx or not. Their patients with skin complaints were 
interviewed about the outcome of the care they received. The CET did not affect time to 
resolution of symptoms or need for return appointments for the same problem in that 
study.  
3.4  Objective 
 The objective of this investigation was to 1) learn why VisualDx did not make a 
difference in patient-level outcomes from the perspective of the clinicians, and 2), to 
identify barriers and facilitators to the use of the CET as experienced by VisualDx users. 
3.5 Study Design 
 We used a convergent, parallel, mixed methods design with a quantitative 
survey and qualitative interviews. [14]. We combined data types to realize a more 
complete analysis and interpretation when exploring the experiences and perspectives of 
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the PCPS who used VisualDx, and to interpret their experience through a behavioral steps 
model adapted from the EBM in practice steps.  
3.6 Methods 
 The methods of the current study included a survey of all participant PCPs 
(users and non-users of the CET VisualDx), and semi-structured interviews of PCPs in 
the active arm (VisualDx users). PCPs from both arms completed a closed answer survey 
on paper or online. Interview participants included only the active arm PCPs i.e. those 
assigned to use the CET. The original trial and the current investigation took place at the 
University of Vermont Medical Center [13]. The subjects included faculty and residents 
in Family Medicine and Internal Medicine primary care clinics.  
 The behavioral steps of the EBM paradigm were used as a reference framework 
to inform the data analyses and evaluate the success and failure of the CET as used by 
PCPs. To realize a more in-depth understanding, we developed a six-step model of how 
clinicians seek evidence, use a CET to answer patient care questions, and apply evidence 
learned to patients. Thus, the model behavioral steps, for the current study were: (S1) 
Recognize a clinical uncertainty, (S2) Decide to seek information, (S3) Navigate access 
technologies, (S4) Use the CET interface and features, (S5) Appraise the information 
found for relevance and quality, and (S6) Apply the evidence to and with the patient. In 
this model, difficulty at any step could block proceeding to the next, thereby reducing the 
likelihood of finding relevant, applicable information in the CET, and preventing an 
impact on patient care. (See Figure 3.1.) 
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Figure 3.1: Model of behavioral steps to use a CET for patient care 
 We organized results from the survey and interviews with the Steps model to 
illustrate the barriers, and facilitators of CET use that the PCPs encountered.  
3.6.1 Quantitative Data and Analysis 
 PCP demographic data and CET usage patterns were available from the CRCT 
baseline survey. In the post-trial survey, PCPs answered questions based on their arm 
during the trial. Questions specific to the VisualDx user arm included: frequency of 
VisualDx use, proportion of skin patients for whom they referred to VisualDx, ease of 
use, and usefulness. Control PCPs were asked if they had used VisualDx or other CETs at 
all during the trial. All were asked if they had used VisualDx after the trial and which 
CET resources, if any, they had used for skin problems in a recent month. (See Figure 
3.2)  
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The survey questions on perceived usefulness and ease of use were informed by the 
Technology Acceptance model [16] All survey data were recorded with REDCap 
electronic data capture tools [17], and analyzed with descriptive statistics in Stata version 
14.2 [18]. The University of Vermont Institutional Review Board approved both the 
original clinical trial and the current investigation.  
Primary Care Provider Survey 
VisualDx user Arm 
During the study, how many times did you refer to VisualDx? 
In what percent of skin problem patients did you refer to it? 
How useful was VisualDx in diagnosing and treating patients?  
Scale 1-4, 1. Not at all, 2. Occasionally, 3. Usually, 4. Always 
How easy or difficult was it to find information you needed? 
Scale 1-4, 1. Very difficult, 2. Somewhat difficult, 3. Somewhat 
easy 4. Very easy  
 
Non-VisualDx user (Control) Arm 
 
During the study participation period (ending July 31 2016), did you refer to 
VisualDx? 
Yes/No 
Both arms 
 
How often have you referred to VisualDx since the trial ended? 
In the last month, how many times did you see a patient for a skin problem? 
In last month, how many times did you look for additional information to 
support care for a patient skin problem. 
In those times, what sources did you use? 
[Check box] DynaMed, Google, Journal articles, PubMed/Medline, 
UpToDate, Textbooks (electronic or print), VisualDx, Wikipedia, Not sure, 
Other. If other, please list. 
 
Figure 3.2: Questions in post-trial surveys of trial participants 
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3.6.2 Qualitative Data and Analysis 
 The principal investigator (MB) conducted semi-structured in-person interviews 
of active group PCPs to ascertain their experiences and opinions about using the CET 
during and since the CRCT. (See Figure 3.3) 
The interviews and surveys were conducted concurrently in February and March 2018.  
The interviews were recorded, transcribed, and coded using NVivo version 12 qualitative 
analysis software [19]. The PI and two independent coders identified themes from the 
interviews. Results were discussed and themes derived from the interview statements by 
three reviewers. Final themes were decided by the PI with reviewer consensus. Themes 
were organized for relevance within the behavioral steps model (Figure 3.1).  
Semi-structured Interview Outline 
Please describe your experience of being (participating) in the study.  
What was your experience like using VisualDx? (Your opinion of it?) (Prompt: how 
useful? hard/easy to use?  
How did you usually access VisualDx? (Prompt: Such as device/network/portal, EHR, 
mobile)  
How did you find your usual method? (Prompt hard/easy, fast, slow? 
What difference did VisualDx make in an aspect of patient care? 
Could you describe a time when it did make a difference or perhaps when you hoped it 
would and it didn’t?  
Do you use VisualDx now? What prompts you to use it or not? 
What other information resources did you use then or do you use now for evidence for 
skin problems? 
What else you would like to tell me about using clinical information resources relevant 
to dermatology or skin problems? 
 
Figure 3.3: Semi-structured interviews outline 
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3.7 Results  
3.7.1 Quantitative Survey Results  
Twenty-one (66%) of 32 PCPs from the original trial participated in the survey: 13 of 17 
from the active group, and 8 of 15 from control group (See Table 3.1). 
Table 3.1: Characteristics of 21 post-trial survey participants 
 Frequency of VisualDx Use  
 All active arm survey respondents reported using the CET multiple times during 
the study, (median 10 times). Seven of eight control arm PCPs did not use it. This 
response indicated general protocol fidelity, confirming that VisualDx users sought 
answers in VisualDx, and that the control group, with one exception, did not use it. 
 Less than half (6 of 13) of VisualDx users reported using it with 50% or more of 
their skin patients. The rather low median of 10 uses of the CET per provider, coupled 
with low use per patient, suggests barriers to effectiveness at Steps 1 and 2. 
 All  Active Control 
N 21 13 8 
Sex (Male), n (%) 10 (47%) 6 (46%) 4 (50%) 
Resident during CRCT (vs. Attending), n 
(%) 
4 (10%) 4 (31%) 0 
Family Med (vs. Internal Med), n (%) 10 (47%) 5 (38%) 5 (63%) 
Provider Education    
Physician, n (%) 20 (95%) 13 (100%) 7 (88%) 
Advanced Practice Nurse, n (%) 1 (5%) 0 1 (12%) 
Years in Practice    
Median 17 12 18 
Range 1-40 1-40 2-39 
Used VisualDx during CRCT, n (%) 14 (67%) 13 (100%) 1 (12%) 
Times used VisualDx during CRCT    
Median  10 --- 
Range  3-125 --- 
Used VisualDx since CRCT (yes), n (%) 14 (67%) 9 (70%) 5 (63%) 
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 Ease of Using of VisualDx  
 The survey asked, “How easy or difficult was it to find information you 
needed?” This question did not distinguish ease of getting to the CET (Step 3) from the 
search and find step in the CET itself (Step 4). Ten respondents (76%) reported that the 
CET was “somewhat easy” or “very easy” to use compared to three (24%) who found it 
“somewhat difficult” or “difficult”. On balance, PCPs reported the CET relatively easy to 
use.  
 Usefulness 
 The survey measured usefulness with the question “How useful was it?” Five 
PCPs (38%) considered it “Usually useful” (3 on the 1-4 scale) while eight (62%), found 
it “not at all” or “only occasionally” useful. None found it “Always/ almost always” 
useful.  
Three of seven (42%) in practice 6 or more years found it not at all useful. No one with 5 
years or less practice found it “Not at all” useful. Responses to the “how useful” question 
most closely mapped to behavioral Step 5, Appraisal for quality and relevance and Step 
6, Apply to and with patient.  
 Frequency, Ease of Use, and Usefulness 
Those who found the CET harder to use used it less often (median 6 times) and those 
who found it easier to use used it more often (median 15). Those who found it harder to 
use found it less useful. Those who found it easier to use were divided equally on 
usefulness: 50% found it never or occasionally useful, 50% found it usually useful.  
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 Years in practice  
 Less experienced PCPs used the CET with at least half of their skin patients 
more often than older providers (67% vs. 29%). They also used it more often (median 15 
vs. 10) and found it easier to use. A higher proportion also found it more useful (50% vs. 
29%). However, these differences were not statistically significant (See Table 3.2). 
Table 3.2: Results for VisualDx frequency of use, ease of use, and usefulness comparing years in 
practice 
 Usage of VisualDx and Other Resources Post-Trial 
There was little difference between users and non-users who had referred to VisualDx 
since the trial. Since the trial, 69% of PCPs in the active arm had used the CET, 
compared to 63% in the control arm, a small and statistically insignificant difference (P= 
0.9 by Fisher’s exact test). In a recent recalled month, UpToDate was used by 11, 
VisualDx by 6, text-books by 6, Google by 4, and Epocrates and DynaMed by one each. 
 All Practice 
Years 
≤5 
Practice 
Years 
>5 
P-
Value 
N 13 6 7 -- 
Median VisualDx Use in 
trial, n (range) 
10 (3-125) 15 (5-30) 10 (3-125) 0.29§ 
Used VisualDx with 
>50% of skin patients, 
n (%) 
6 (46) 4 (67) 2 (29) 0.62ɸ  
Ease of use, n (%)     0.06ɸ  
 Harder 3 (23) 0 (0) 3 (43)  
 Easier 10 (77) 6 (100) 4 (57)  
Usefulness, n (%)     0.43ɸ  
 Less useful  8 (62) 3 (50) 5 (71)  
 More useful  5 (38) 3 (50) 2 (29)  
§ Spearman Rank, ɸ Fisher’s Exact Test 
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3.7.2 Qualitative Interview Results 
 Eleven active group PCPs participated in interviews, including three residents 
and eight attending physicians (See Table 3.3). Two active group PCPs who participated 
in the post-trial survey did not participate in an interview. 
Table 3.3: Profile of active group survey and interview participants’ status during CRCT 
PCP code Resident/ Attending Specialty Sex Years in Practice 
PCP01 Resident IM Female 1 
PCP02 Attending FM Male 32 
PCP03 Attending IM Male 34 
PCP04 Attending IM Female 17 
PCP05 Attending FM Female 40 
PCP06 Attending IM Male 4 
PCP07 Resident IM Female 3 
PCP08 Resident IM Female 3 
PCP09 Attending FM Female 4 
PCP10 Attending IM Male 22 
PCP11 Attending FM Male 24 
PCP98 (survey only) Attending FM Male 12 
PCP99 (survey only) Resident IM Female 1 
We assigned themes to provider statements and noted where the statement fell in the 
Steps framework based on the content of the statement. Eleven relevant themes included: 
dermatology confidence, attitude or intention, time pressure, other sources, access, skills 
needed, interface difficulty, diagnosis support, irrelevance, patient communication, and 
impact on patient management. Within themes, facilitators were factors that promoted 
use of VisualDx, or that had beneficial impact on the PCP practice or the patient. Barriers 
were defined as inhibitors of use of the CET or deterrents to its usefulness and 
effectiveness. (See Appendix V) 
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 Recognizing Uncertainty in Skin Disease (S1) 
This step, recognizing uncertainty when a patient presents with a skin disease problem, 
set the PCP on the path to seeking new information. Dermatology, especially diagnosis of 
rashes, was recognized by providers as an area of frequent uncertainty in primary care. 
The recognition of uncertainty in skin disease care signaled more openness or intention to 
seek information; therefore, we considered it a facilitator of VisualDx use.  
“There are certain areas, [like dermatology] where internists in particular, don't 
have as much training and we tend to fall into…less rigorous ways approaching a 
diagnosis.” PCP10  
Several interviewees stated that because of their own uncertainty in dermatology, 
evidence-based information resources were especially needed in that domain.  
“[Dermatology] is way harder because we just don’t have the exposure. Also, so 
much of it is how it looks rather than like a description of symptoms. So, I think 
something like VisualDx is totally necessary.” PCP07  
“[Dermatology] is an area that I feel I continue to work towards improvement in 
versus some other areas where I feel very prepared and skilled…” PCP09 
Self-described knowledge or confidence in dermatology was a barrier to information-
seeking because highly confident PCPs recognized uncertainty less often and needed the 
CET less. Physicians with 32 and 24 years’ experience noted their comfort with existing 
knowledge. 
“If it's a simple thing that you kind of deal with a lot and you feel like you know 
what it is and how to treat it, then you obviously wouldn’t use the resource in that 
situation.” PCP02 
“There were certainly a lot of patients where I felt comfortable with what I 
thought the problem was” PCP11  
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 Decision to Seek Information in VisualDx (S2) 
 This step encompasses the decision to act on an uncertainty by seeking answers 
to patient-related questions. Themes of intention to obtain information and availability of 
competing sources were included in this step.  
A positive intention toward using VisualDx was a facilitator for continuing use of 
the CET throughout the trial. Some PCPs recounted the specifics of their assigned 
protocol as evidence of their intention and commitment to use the CET during the trial.  
“When I had a patient that had a skin complaint, I was supposed to open VisualDx 
and use it to come up with a diagnosis or treatment…I tried to be pretty diligent 
about it.” PCP01 
“I think I probably used it close to every time I saw a skin problem, unless it was 
super obvious…But even then, I would look it up and use it to get ideas for 
treatment recommendations.” PCP08 
For some, being in the study was a benefit in itself and motivated them to use it. They 
saw it a as a learning opportunity that could improve their practice.  
“I was glad I was in the intervention arm of the study, because…it was motivation 
for me to use it [VisualDx] more and see how it changed my practice…” PCP08 
PCPs did not always look for answers even with uncertainty present. Time pressure in a 
patient visit made pursuit of any information in VisualDx or other CET less likely.  
“When you're already 45 minutes behind and you got patients waiting and 
someone comes in with a goofy-looking rash, it's very easy to say "Well, I think 
it's this, let's try it, if it doesn’t work call me back…” PCP10  
Some PCPs anticipated that diagnosis search on the CET would be time consuming, so 
they seldom used the differential diagnosis tool but did use the CET to find treatment 
options.  
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“You know, [VisualDx] is time consuming and…you're busy. It’s easier to get at 
treatment than it is to get a differential because it just takes longer. And I was less 
likely to do that [differential] part.” PCP02 
Use of other resources instead of VisualDx was also a barrier at Step 2. PCPs felt that 
colleagues or other resources would be faster or more convenient and so used them 
instead of the CET despite their active arm protocol.  
 “I was working…next to a skilled, older practitioner. So often times my first 
recourse would be going to him, asking him to take a look. So that may have 
decreased my use… Sometimes I just used Google Images” PCP09  
Several PCPs reported using VisualDx to reduce diagnosis uncertainty but another source 
for treatment or management decisions.  
“If I knew what the problem was…but wasn't sure how to manage it, I might use 
UpToDate [more].” PCP11 
Several providers reported using UpToDate for skin problem questions, even though it is 
not specialized for skin problems. 
“I used UpToDate quite frequently. And I used Micromedex quite frequently…I 
don’t think my use of VisualDx changed my rates of use of those other 
resources.” PCP08  
 Access to VisualDx (S3) 
This step occurred when the PCP navigated the hospital network, medical library website, 
or a mobile device to reach the CET. Based on the interviews, access through the 
electronic medical record (EHR) was an important facilitator. All interviewees described 
the EHR as virtually the only way they used VisualDx. The ubiquity of networked desk-
top computers in exam rooms and offices were additional facilitators. The mobile version 
of the CET was available on smart phones and tablets, but no participant reported using it 
for patient care.  
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“I always went to it on a desktop through [EHR]. Never through the hospital 
intranet. Never used the mobile. When I’m in clinic I don’t use my phone. We’re 
always on the computer, writing the notes, or looking at vitals, looking at 
meds…” PCP01 
Easy point-of care access was essential for some to even consider using a CET. 
“…It's difficult, for clinicians that are in a fast-paced clinical environment, to be 
able to stop and reference things if you don't have it immediately at your 
fingertips.” PCP11 
One PCP developed problems accessing the resource after one month into the study and 
never got back on track using the resource.  
“[It was] moderately useful in the beginning but then, I couldn’t access it. I asked 
for help…and maybe I got a response. But maybe I didn’t…follow the answer, 
and I didn’t use it again.” PCP05  
 VisualDx Interface and Features (S4) 
 PCPs next step after navigating access was to utilize the CET’s interface and 
features. Some found it easy to learn and use while others doubted their skill to use it 
effectively. A majority stated that they found the CET easy to use, requiring only a slight 
learning curve. This confirmed the survey results, particularly among those with 5 or 
fewer years in practice.  
“…Once I knew what I was doing, it wasn't hard to use.” PCP06  
“I would say it's fairly easy…There was a small learning curve to…figure out the 
best way to use it.” PCP08 
 Others found the interface a barrier and found the interactive diagnosis tool 
difficult or unpredictable. Even though PCPs viewed a brief training tutorial, some felt 
they lacked the skill to use it effectively and questioned whether they were at fault for not 
getting better search results. 
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“I remember staring at it saying, when I was trying to figure out what this rash 
was, ‘Where do I put the information in?’. So, it wasn't as user-friendly for data 
input.” PCP10 
“The output is not always coming up with the most common causes…Or the 
things I'm most likely to think it is…So I'm not sure if I’m just not putting in 
enough [information]” PCP09 
 Appraise for Quality and Relevance (S5) 
 In step 5, the PCP evaluated or appraised the evidence presented by the CET for 
quality and relevance to their information need. PCPs considered VisualDx as validated 
by expert dermatologists and sufficiently reliable to serve as “best available” evidence. 
Several noted that it was more reliable than images on an internet search engine. 
“I had a lot of confidence that the material was accurate and properly edited or 
authenticated by experts in the field. I didn't have any concerns about that.” 
PCP03 
“The problem with Google Images is [that] anybody…can upload a picture and 
tag it with a diagnosis. At least VisualDx has been validated by somebody that 
these pictures are the real deal.” PCP10 
 PCPs, especially those with fewer years in practice, found the CET’s’ interactive 
diagnostic tool useful when they were “starting from scratch” with little idea of the 
diagnosis. The ability to broaden the differential [diagnosis] was useful especially to 
residents and those newer to practice.  
“I did, on a few occasions, have no idea what I was looking at in the patient and 
used it to try to figure it out.” PCP08  
“…I would often look at a skin lesion or rash and have an idea…and then I would 
put information into VisualDx and it would broaden my differential and 
sometimes completely change my initial opinion.” PCP07 
“…I had this young woman with…this rash on her back, I…thought maybe 
psoriasis, and then used VisualDx. Based on what I found, it looked more like 
pityriasis rosea so I went that way instead.” PCP08 
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Even experienced physicians wished to expand the differential diagnosis at times. 
“If something is really weird and I’m trying to figure out what are the possibilities 
here, it certainly helps generate a list of possible conditions.” PCP10  
Several experienced providers reported that the CET confirmed a diagnosis and enhanced 
their diagnostic confidence.  
“A niche for VisualDx is when you think you know what it is but you just want to 
make sure you haven’t forgotten something.” PCP10 
“I can definitely say it helped me feel…more confident about a diagnosis.” 
PCP02 
 Although fewer PCPs reported using the CET for treatment decisions, those who 
did found it current and useful.  
“Treatment recommendations? I definitely used it for those. If I had tried the 
usual things you try in the primary office…it was helpful to see some of the other 
treatment options…available on there.” PCP01 
An experienced PCP found the treatment recommendations especially relevant for 
updating his usual practice.  
“One case was a fungal infection on the nails…There was a new topical treatment 
option that had recently been FDA-approved and I hadn’t used it before.” PCP02 
 On the other hand, the barrier of useless or irrelevant information in the CET 
came up frequently. 
“Just as frequently as I found that it was helpful, I found that it was not helpful at 
all…I mostly got a lot of extraneous information and things that…weren't 
appropriate for what I was looking for…So some of that time using it was 
wasted” PCP08 
Some experienced clinicians felt that broadening the differential was not useful for them. 
They preferred a tool that would help them narrow or confirm the diagnosis. VisualDx 
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was not as useful for that because the diagnoses and images retrieved were excessively 
broad.  
“So, at least for my level of experience, it didn't offer me a whole lot in terms of 
narrowing my differential diagnosis. It was a lot more about broadening it, and 
I'm not sure if that was helpful to me.” PCP03 
There was often too much or irrelevant information. The information retrieved needed to 
be sifted or a new search launched which consumed valuable time. 
“If you put basal cell carcinoma into VisualDx, it’s a thousand pictures of every 
possible way a basal cell carcinoma can show up - which can be misleading, 
because it's not showing you what the typical ones are. So…it's almost too much 
information.” PCP03 
I remember getting more hits back…a lot more diagnoses - than I was expecting -
- some of which didn't even look close to what I described.” PCP10 
 A barrier to this CET making a difference was that PCPs used it as one tool 
among others rather than relying in it alone. Some PCPs used VisualDx less because they 
preferred other sources.  
“I have a favorite dermatology book that I use like I would use VisualDx.” PCP10 
“If there was something I was worried about or I didn't know, I'd look in 
VisualDx but then I'd really rely on [a colleague]: Hey do you mind coming to 
look at this?” PCP07 
“…If I thought of something, I’d look it up on UpToDate [also] and see if the 
pictures and descriptions matched” PCP06 
 Apply to and with Patient (S6) 
 In this step, the PCP applied the information from VisualDx to the patient. 
Applicable themes included patient communication, management, i.e. treatment or 
referrals, and “no difference” (no impact on management). 
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 Most PCPs found VisualDx useful for communication, decision agreement, and 
building rapport with patients. Several said it helped show patients how their condition 
had changed or improved. Several PCPs reported that they shared what they learned on 
the CET with the patients to help explain their condition.  
“[I used it with patients] a couple of times, especially if they had something that 
went away; then they could say "Oh it did look like that", kind of self-report. [It 
was helpful for] patient communication and education, absolutely.” PCP04  
“If you are able to say, “This is really just eczema and this is what eczema looks 
like on other people, and it’s just like yours”, it gives you a kind of rapport with 
them.” PCP01 
Some reviewed alternative diagnoses and images with patients during the visit to reach 
agreement with them. 
“I would open it up on the computer in the patient’s room oftentimes, and go 
through it [all] with them.” PCP06 
“I would look at VisualDx and it would give me four additional ideas. So, then I 
would talk to the patient more, come up with a diagnosis that I thought was likely 
enough…to act on.” PCP08 
The PCPs who used images with patients found them helpful for communication and 
understanding.  
“…If you can use a visual to show somebody and say, "Oh this looks like really 
what you have," they gain a little bit more confidence.” PCP09 
 Some PCPs reported that VisualDx influenced therapy and referral decisions, 
and advice to patients and caregivers.  
“A patient came in and he was pretty convinced he had poison ivy and I was 
pretty convinced that he didn’t…I ended up using [VisualDx], and he was right. I 
would have treated it differently had I not opened it and used some of the pictures 
to help.” PCP01 
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Some PCPs stated that using the CET altered their referral patterns, prompting some 
referrals and avoiding others. Those making fewer referrals cited having more confidence 
as the reason.  
“A lady came in with something strange on her eyes and we couldn’t figure out 
what it was. Based on using VisualDx I came up with something I hadn’t 
considered that was treated quite differently. That did prompt a referral to 
dermatology.” PCP01 
“I think it changed my rate of dermatology referrals because I willing to diagnose 
skin conditions with…more confidence and to act on those diagnoses.” PCP08 
Despite positive examples of application to the patient and differences in management, 
others did not recall any impact that using the CET made.  
“Care difference? I would have to say no, that it didn't really offer me a different 
path forward”. PCP03 
“I can't think of a particular instance where it clinched it for me or made a clinical 
decision distinction or difference. It was more of a tool that I used to augment 
whatever I was looking into otherwise.” PCP09  
3.8 Discussion  
3.8.1 Barriers 
 This mixed methods study identified facilitators and barriers to effective use of 
VisualDx and its impact on PCP decisions and patient care management. Although there 
were facilitators and benefits, PCPs experienced significant barriers to using the CET. 
Barriers included lack of perceived need, time pressure, use of other resources, difficulty 
of interface, irrelevance of information retrieved, and low impact on care management. 
The greatest single barrier to the CET use appears to have been the frequency of 
retrieving irrelevant information (“about half the time”), and the frustration and wasted 
time that engendered. Several held the view that the CET had no impact on case 
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management. In the survey, more PCPs found it “never” or “occasionally” than 
“usually”. Similarly, lack of relevant information retrieved [4, 21] and insufficient time 
have been described in previous studies [20].  
 Seeking information from multiple sources is typical information-seeking 
behavior for clinicians. [1, 21]. In the current study, PCPs also utilized multiple sources, 
but they preferred CETs easily available from within in the EHR or at the point-of-care 
including UpToDate, Google Images, and print textbooks. Although there is an intrinsic 
value to having multiple sources, their presence served as a barrier to the use of VisualDx 
and, when they are effective, decreases the impact that the CET has on clinical outcomes.  
3.8.2 Facilitators and Benefits  
 Positive intention to use the CET and accessibility via the EHR facilitated use. 
PCPs did not often use other dermatology-relevant CETs, such as electronic dermatology 
text-books, MEDLINE and dermatology journals available to them on the medical library 
website because they were less convenient and took them out of the EHR environment.  
 Expansion of the -differential diagnosis, and confirmation of diagnostic 
decisions were benefits expressed in the interviews. Diagnosis support was 
“occasionally” or “usually” useful. PCPs in practice five years or less, including 
residents, appreciated the differential diagnostic support more than senior providers. 
Those in practice longer preferred to narrow or confirm a diagnosis more, but they were 
sometimes disappointed with excessive results. 
 Successful use of the CET for patient communication and shared decision-
making at Step 6 was an unexpected benefit. This benefit could have affected patient 
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satisfaction with care, an outcome that was not evaluated in this investigation but could 
be evaluated in future research. 
3.8.3 Impact on Patient Management  
 PCPs recalled cases when use of VisualDx made a difference in care 
management in terms of treatment and referrals (Step 6). The CET altered referral 
patterns, though the differences were in both directions: prompting some referrals and 
avoiding others. Use of the CET may have resulted in more appropriate referrals, but not 
a reduction in the overall number of return appointments, an outcome measured in the 
clinical trial. The interviews confirmed that, at least at times, PCPs believed there were 
practice improvements after using the CET.  
 According to a large qualitative study of clinicians, efficiency, defined as brief 
time to find information and the high relevance of information found, was the most 
important factor in provider satisfaction with CETs at the point of care [22]. By this 
criterion, the CET studied here could improve efficiency because of its perceived 
convenient access through the EHR and its perceived ease of use, thus overcoming 
barriers of time and access to evidence. On the other hand, the need or habit of clinicians 
to use other resources and the occasions when information retrieved was irrelevant 
contributed to inefficiency. 
3.8.4 Strengths and Limitations of this Study  
 This investigation extended previous work on one CET’s value in the Primary 
Care dermatology domain. The population studied included PCPs with varying 
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experience and backgrounds. Mixed methods enriched our understanding of the users’ 
experiences and allowed us to compare results obtained by different methods.  
 The study took place in one academic health center thereby limiting 
generalizability to other settings. Outcomes reported were the view of the providers and 
not verified by patients or other data sources. Although recall errors are possible in any 
retrospective report, all participants recalled their participation and responded to survey 
and interview questions without difficulty.  
3.9 Conclusions  
 This mixed methods investigation identified facilitators and barriers to PCPs use 
of a CET for dermatological problems that may help explain the results of the prior 
randomized trial. Despite offering high quality information and interactive diagnostic 
features, VisualDx was not sufficiently easy to use, or consistently useful enough to 
motivate PCPs to use it frequently or exclusively. Therefore, it did not make a 
measurable difference in provider acceptance or patient outcomes. This assessment could 
be used by medical informaticists and medical librarians responsible for acquisition and 
implementation of dermatology CETs in academic medical center settings. 
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APPENDICES 
Appendix I : Provider Eligibility and Baseline Survey 
This survey was administered to Primary Care Providers through REDCap following 
their consent to participate.  
Eligibility Screening Questions: 
1. What is your medical or professional degree?  
o Physician  
o Physician Assistant  
o Advanced Practice Nurse  
o None of the above  
 
2. Are you currently seeing patients at a UVMMC Family Medicine or Primary Care 
Internal Medicine Clinic?  
o Yes 
o No 
 
3. Do you agree to adhere to the procedures of the study depending on the group you 
are randomized to?  
o Yes 
o No 
o Not sure. Please call me.  
 
Answers to Q 1. must be Physician, Physician Assistant, or Advanced Practice 
Nurse. Answer to Q. 2. must be yes. Answer to Q. 3. must be yes to be enrolled in the 
study and continue to baseline survey. 
 
Baseline Survey in the Information for Skin Problems in Primary Care Study.  
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1. In the last month, how often did you refer to a print or electronic information source to 
support patient care?  
o None at all  
o 1-3  
o 4-6  
o 7-9  
o 10 or more times  
2. Which information sources did you use to support patient care? (Check all that apply.)  
□ DynaMed  
□ Google  
□ Journal Articles  
□ PubMed/Medline  
□ UpToDate  
□ Textbooks (electronic or print)  
□ Visual Dx  
□ Not sure/don't remember  
□ Other  
3A. If other, please specify.  
__________________________________  
The next three questions refer to when you saw patients for skin problems.  
 
4. In the last month, how many times did you see a patient for a skin problem?  
o None at all  
o 1-3  
o 4-6  
o 7-9  
o 10 or more times  
5. In the last month, how many times did you look for additional information to support 
care for a patient skin problem?  
o None at all  
o 1-3  
  99 
o 4-6  
o 7-9  
o 10 or more times  
6. Recalling those times when you sought information for a patient skin problem, what 
sources did you use? (Select all that apply.)  
□ DynaMed  
□ Google  
□ Journal Articles 
□ PubMed/Medline  
□ UpToDate  
□ Textbooks (electronic or print)  
□ Visual Dx  
□ Not sure/don't remember  
□ Other  
6A. If other please specify: __________________________________  
Information About You  
7. What year did you graduate from professional school? _____________ 
8. Are you in a residency program?  
o Yes  
o No 
9. Primary Care Specialty  
o Family Medicine  
o Internal Medicine  
o Other  
 9A. If other please specify: __________________________________  
10. Your usual practice location:  
o Family Medicine Berlin  
o Family Medicine Colchester  
o Family Medicine Hinesburg  
o Family Medicine Milton  
o Family Medicine South Burlington  
o Urgent Care Colchester  
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o Adult Primary Care South Burlington  
o Adult Primary Care Essex 
o Adult Primary Care Burlington  
o Adult Primary Care Williston  
11. What is your gender?  
o Female  
o Male  
o Other  
12. Please let us know here if you have any questions or comments. 
__________________________________________  
We will email you in a few days with an orientation for the procedures for your 
randomized group. 
End of Provider baseline survey  
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Appendix II: PCP Active Group Educational Tutorial 
Information for Skin Problems 
in Primary Care Study
Provider Orientation and Procedures 
Center for Clinical and Translational Science
University of Vermont
 
Welcome
Thank you for agreeing to participate in this 
research. 
This learning module will help you participate in the  
study in an efficient and effective way.
The module will take about 5 minutes to review.
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Your Group Protocol
▪ Your group protocol is to refer to VisualDx, a dermatology 
information source, when you see a patient for a skin 
problem. 
▪ If you have any uncertainty about appearance, diagnosis, 
treatment, or prognosis of a skin problem or want to share 
information with a patient, please use VisualDx. 
 
Your Group Protocol
▪ The referral to VisualDx related to the patient skin 
problem could be anytime before, during, or after a visit, 
▪ The lookup could be brief to confirm something you 
already know or to share an image or description with 
your patient.
▪ The lookup would be longer if you have more concern 
about the diagnosis or treatment of the problem.
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What Is VisualDx?
▪ VisualDx is a clinical knowledge and diagnostic support  
resource that is licensed by UVM Medical Library to 
support providers and patient care.
▪ It contains over 100,000 images of skin and other visible 
conditions.
 
How Do I Access VisualDx? 
▪ PRISM
▪ UVMMC Intranet Desktop
▪ Dana Medical Library website
▪ Your Mobile Device (app)
There are 4 main ways:
The next few slides will provide instruction on each access method.
.
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From the PRISM Home Screen
▪ Click the blue EPIC button at 
the top left of PRISM screen 
for a dropdown menu
▪ Click on Reference Links for 
another dropdown menu
▪ Click on VisualDx
 
From the UVMMC Intranet
▪ On the UVMMC intranet home page
▪ Look for the Applications box and click the 
General button 
▪ Click on Dana Medical Library
▪ This will bring you to the Dana Library 
website
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From the Dana Library Website
▪ Click the Articles and Database link
▪ Scroll down to the Clinical 
Databases section in the left hand 
column
▪ Click the VisualDx link
▪ Bookmark the page for convenience.
▪ Your most direct link to VisualDx is 
through PRISM or Mobile app.
 
To Access VisualDx from your Mobile Device
▪ Go to PRISM or Dana Library website
▪ Go to VisualDx
▪ Directions for registering and 
downloading the app are on the opening 
page. Click on the icon.
▪ Video: http://www.visualdx.com/video-
tutorials/visualdx-mobile
The next two slides introduce ways to use VisualDx.
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How to use VisualDx: Differential Builder
▪ The differential builder is a 
distinguishing feature of VisualDx. 
Click on the blue Differential Builder 
button to start.
▪ The builder will prompt you for 
patient age, lesion type, body 
location, appearance, and other 
findings.
▪ VisualDx will display images and 
diagnoses that match all the criteria 
you selected.
 
VisualDx Features
▪Please take time to become familiar and fluent with using VisualDx.
▪ For more information, see the educational videos at the VisualDx 
website: http://www.visualdx.com/visualdx-videos/5-minute-
overview-and-demo
▪If you have any problem using VisualDx easily, contact Gary 
Atwood MLS, Study Team member and Education Librarian at 
Dana Medical Library at Gary.Atwood@uvm.edu or 656-4488.
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Other Procedures: 
What Happens After the 
Patient Visit?
▪ PI identifies your eligible 
patients in PRISM.
▪ Study team sends each patient 
a letter over your name 
informing them of the study. 
▪ We ask that you provide your 
signature to include on the 
letters to your patients.
 
Additional Information about the PCP Role  
▪ Both PCPs and patients are subjects in this study.
▪ 30 or more providers and 300 patients, an average of 10 patients per 
provider, will participate. 
▪ We will contact you every 2 weeks by email or phone to update you on 
the progress of the study and answer any questions.
▪ We will notify you when we have recruited enough patients so that you no 
longer need to follow the protocol. 
▪ Anticipated duration of your involvement is 6 – 12 weeks.
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Questions or concerns?
If you have any problem using VisualDx easily, contact Gary Atwood MLS, Study Team 
member and Education Librarian at Dana Medical Library at Gary.Atwood@uvm.edu or 
656-4488.
If you have a concern about the study or its procedures, please contact the Principal 
Investigator, Marianne Burke, MA-L, at the Center for Clinical and Translational Science, 
4th fl. Given Courtyard South, UVM,  by email  mburke@uvm.edu or phone 802-236-0075. 
This research protocol was approved by the UVM/UVMMC Committee on Human Subjects 
Research, June 10, 2015.
Thank you for completing this module. We recommend you download it for your reference. 
Please return to the REDCap survey page to answer 1 question.
Center for Clinical and Translational Science
University of Vermont
656- 4560 
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Appendix III: PCP Control Group Educational Tutorial 
Information for Skin Problems 
in Primary Care Study
Provider Orientation and Procedures 
Center for Clinical and Translational Science
University of Vermont
 
Welcome
Thank you for agreeing to participate in this 
research. 
This learning module will help you participate in the 
study in an efficient and effective way. 
The module will take about 5 minutes to review.
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Your Group Protocol
▪ You will see patients for skin problems as you normally 
do.
▪ Note the skin problem discussed or treated during the visit  
in the PRISM patient record as you normally would.  
 
Your Group Protocol
▪ According to your group protocol, you may choose to refer 
to an additional information source concerning the skin 
problem or not.
▪ Refer to any textbook or electronic resource as you 
normally would or not. 
▪ Except – Do not refer to VisualDx.
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Other Procedures: What 
Happens After the  
Patient Visit?
▪ PI identifies your eligible 
patients in PRISM
▪ Study team sends each patient 
a letter over your name 
informing them of the study. 
▪ We ask you to provide your 
signature to include on the 
letters to your patients.
 
Additional Information about the PCP Role  
▪ Both PCPs and patients are subjects in this study.
▪ 30 or more providers  and 300 patients, an average of 10 patients per 
provider, will participate. 
▪ We will contact you every 2 weeks by email or phone to update you on the 
progress of the study and answer any questions.
▪ We will notify you when we have recruited enough patients so that you no 
longer need to follow the protocol. 
▪ Anticipated duration of your involvement is 6 - 12 weeks.
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Access to Clinical Knowledge Resources
Dana Medical Library provides access to electronic clinical 
knowledge resources to support evidence-based patient care: 
• Medical research journals.
• Medical e-text books in primary care and specialties.
• PubMed database with links to full text journal articles
• Mobile clinical apps. 
You can access these resources from many different 
locations.
 
FYI: How to Access Clinical Information Sources
▪ PRISM
▪ UVMMC Intranet Desktop
▪ Dana Medical Library website
There are 3 main ways:
The next few slides will provide instruction on each access method
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Access From PRISM
▪ Click the EPIC button
▪ Click on Reference Links for menu
▪ Click on Dana Library Main to 
connect to the library’s web site.
▪ UpToDate and Micromedex are 
also available here. 
▪ Do not use VisualDX.
 
From the UVMMC Intranet
▪ Log in with M number
▪ On the UVMMC intranet home page
▪ http://intranet.fletcherallen.org
▪ Look for the Applications box and click the 
General button 
▪ Click on Dana Medical Library
▪ This will bring you to the Dana Library 
website
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Access from the Dana Medical Library Web Site
http://library.uvm.edu/dana
▪ Click on PubMed etc.
▪ OR Click the Articles and 
Databases link.
▪ Scroll down to the Clinical 
Databases section in the left hand 
column.
▪ Find multiple clinical information 
resources.
▪ From Off Campus: Log on using M 
number and password.
 
Questions or concerns?
If you have any problems referring to library resources easily, contact Gary Atwood MLS, 
Study Team member and Education Librarian at Dana Medical Library at 
Gary.Atwood@uvm.edu or 802-656-4488.
If you have a concern  with any aspect of the study protocol please contact the  Principal 
Investigator, Marianne Burke at mburke@uvm.edu or phone 802-236-0075. 
This research protocol was approved by the UVM/UVMMC Committee on Human Subjects 
Research, June 10, 2015.
Thank you for completing this  module.  We recommend you download it for your 
reference. Please return to the REDCap survey page to answer 1 question.
Center for Clinical and Translational Science
University of Vermont
656-4560
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Appendix IV: Patient Interview Data Collection Instruments 
Patient telephone interview/Questionnaire at ~30 days after index visit for the skin 
problem. Study team investigators including trained research assistants reached identified 
eligible patients by telephone 30 days or after post the index visit for the skin problem. 
After review of the lay summary, and verbal consent from the patient, the following 
interview was conducted.  
1. Our records show that you saw (provider name) for a skin problem about (date of 
visit). Does that sound right?  
o Yes – Go to question 2 
o No – If patient cannot recall the problem or the visit, call is ended and patient is 
ineligible (dis-enrolled).  
2. Is (provider name) your usual primary care doctor?  
o Yes 
o No 
3. Since you saw (provider name) for the skin problem last month have you gone back to 
him/her or to any other doctor for a follow-up appointment for this same problem?  
o Yes – Go to question 4 
o No – Go to question 6 
3A. How many other appointments did you have? 
__________________________________  
3B. What kind of doctor did you see for the follow up appointment?  
□ Primary Care 
□ Dermatologist 
□ Other  
3C. If other, what kind? __________________________________  
4. Since that visit with (provider name), would you say the skin problem is:  
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o All Better If all better Go to 4A, 4B, 4C,4D 
o Improved – GO to 5 
o Unchanged – GO to 5 
o Worse – GO to 5 
4A. About how long after that visit did it take to be all better? 
______________________________ 
4B. How many days or weeks after the appointment was it all better? 
__________________________________  
4C. Would you say that this time frame is exact or approximate?  
o exact  
o approximate  
4D. If it's easier, thinking back from today, how many days or weeks ago 
did you think the problem was all better? [Answer could be in days, weeks, or 
a date.]  
__________________________________  
After patient answers 4A, or 4B, or 4C with enough clarity to determine 
number of days - Go to Question 6. 
5. Do you plan to see a provider (of any kind) again for this same skin problem?  
 Yes – GO to 5A 
 No – GO to 6 
5A. What type of doctor will you see?  
□ Primary Care  
□ Dermatologist  
□ Other  
5B. If other, what type? __________________________________  
6. Thank you. Now, I'd like to ask a couple of questions about you. 
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 How old are you? __________________________________  
7. What is your sex?  
o male  
o female  
o other 
After Question 7, Go to End call 1 or End call 2 depending on problem status. 
End call 1: Patients who were “All Better”  
Thank you for helping with this research. I have all I need and won't need to call you 
again.  
Do you have any questions or comments? 
 (Record if any)_________ 
Thank you for your participation. Goodbye. 
End call 2: Patients who were improved unchanged or worse.  
We're coming to the end of questions today. I'll call you again in about 4 weeks to see if 
anything about the skin problem has changed. Thank you for your participation. 
------------------------------------------------------------------------------------------------------------ 
 
60 Day or Second Patient Telephone Interview  
 
1. Hello (patient’s first name) (patient’s last name). This is (caller name) from the UVM 
Medical Center research on skin problems. We spoke with you a month ago about a skin 
problem you saw Dr. (provider name) for. Do you remember talking with us?  
o Yes  
o No 
2. When we spoke with you before, you described the problem as (problem status: 
Improved, Unchanged or Worse). Does that sound right?  
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o Yes  
o No 
3. Since I (or team member name) spoke with you before on (date of call) about the skin 
problem visit, have you gone back to Dr. (provider name) or any other provider for this 
same problem?  
o Yes --- GO 3A and 3B 
o No – Go to 4 
3A. Since we spoke with you last time, how many appointments have you had for this 
same problem? __________________________________ 
3B. What type of doctor did you see for this appointment(s)?  
□ Primary Care  
□ Dermatologist 
□ Other  
If other, what type? 
__________________________________  
4. Since that (First) visit with Dr. (provider name) and our conversation last month would 
you say the condition is:  
o All Better ---If all better, go to 4A,4B, or 4C,4D 
o Improved ---Go to 5 
o Unchanged ---Go to 5 
o Worse ---Go to 5 
4A. When did you realize the skin problem was all better? (Look at calendar try to 
approximate days after call.)  
__________________________________ 
4B. Looking at a calendar, that was about ( day/date) about _____(days Time) after 
we talked 
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__________________________________ 
4C. If it's easier, thinking back from today, can you recall how long ago you realized 
the problem was all better? When was that?  
__________________________________ 
4D. Would you say that number of days is exact or approximate?  
o Exact number of days 
o Approximate number of days 
After determining the days since index visit or date (all better), GO to End Call 1 
5. Do you plan to see a doctor or health care provider again for this condition?  
o Yes – Go to 5A 
o No -   Go to End Call 2 
 5A. What type of doctor are you planning to see next?  
□ Primary Care  
□ Dermatologist  
□ Other 
 If other, what type? 
 Go to End Call 2 
End Call 1: Thank you for helping with this research.  
I have all I need and won't need to call you again. Do you have any questions or 
comments? 
 __________________________________ 
End Call 2: We're coming to the end of questions today. I'll call you again in about 4 
weeks to see if anything about the skin problem has changed.  
---------------------------------------------------------------------------------------------------- 
90 Day (Final) Patient Questionnaire 
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Hello (patient’s first name) I'm calling from the University of Vermont Medical Center 
about the skin problems study.  
I (or one of my team members called you about (3 or 4) weeks ago with questions about 
what happened with a skin problem you saw doctor (provider name) for.  
1. Do you remember?  
o Yes  
o No 
2. When we spoke with you before said the problem was... INTERVIEWER SAYS 
WHICH (improved, unchanged, or worse) Does that sound right?  
o Yes  
o No 
3. Since I (my team member) spoke with you before (4 weeks ago) (date of call) about 
your skin problem visit, have you gone back to any other doctor or provider for this same 
problem?  
o Yes -- GO to 3A-C 
o No -- GO to 4 
3A. How many follow up appointments?  
__________________________________  
3B. What type of doctor did you see for this appointment(s)?  
□ Primary Care 
□ Dermatologist  
□ Other 
3C. If other, what type? __________________________________  
4. I'm going to ask you how the skin problem is doing.  
Since that first visit with Dr. (provider name) and our conversation last 
month would you say the condition is:  
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o All Better GO to 4A-D 
o Improved –GO to 5 
o Unchanged – GO to 5 
o Worse – GO to 5 
 
4A. So about when did you realize the skin problem was all better? 
__________________________________ 
4B. Looking at a calendar, that was about (suggest day/date) That was about 
_____(Time) after we talked.  
__________________________________ 
4C. If it's easier, thinking back from today, can you recall how long ago you 
realized the problem was all better? When was that?  
__________________________________ 
4D. Would you say that number of days is exact or approximate?  
o exact  
o approximate  
GO to 5 End Call 
5. End Call (All): 
We have come to the end of the call and your participation in the study. Thank you so 
much for your help. Do you have any questions or comments before we end the call? 
(Record comments if any)________________________ 
Again, thank you very much. Goodbye 
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Appendix V: Schema of Themes with Exemplar Quotations and Relevant 
Behavioral Step and Barrier or Facilitator Effect 
 
Theme PCP Exemplar Quotations (Years in Practice) Step#: 
Effect 
Knowledge 
confidence 
“There were a lot of patients where I felt comfortable with what the 
problem was.” PCP11 (24 yrs.) 
S1: Barrier 
Attitude and 
Intention 
“I think I used it close to every time I saw a skin problem, unless it 
was super obvious…But even then, I would use it to get treatment 
recommendations. PCP08 (3 yrs.) 
S2: 
Facilitator 
Time “When you are already 45 minutes behind schedule and someone 
comes in with an [odd] rash, “It’s easy to say, I think it’s this, try it, 
if it doesn’t work call me back”. PCP10 (22 yrs.)  
S1, S2 
Barrier 
Other sources “I was next to a skilled older practitioner so my first recourse might 
be to go to him. So that may have decreased my use” PCP09 (4 yrs.) 
S2: Barrier 
Other sources “I have a favorite dermatology book I use like I would use 
VisualDx.” PCP10 (22 yrs.) 
S5: Barrier 
Other sources “If I knew what the [diagnosis] was but didn’t know how to manage 
it, I might use UpToDate [more].” PCP11 (24 yrs.) 
S5: Barrier 
Technology: 
EMR access 
“If I’m seeing patients, I’m already in the EMR, and VisualDx is 
there. It’s easy to find. 99% of the time that’s what I’d do.” PCP11 
(24yrs.) 
S3: 
Facilitator 
Technology: 
CET interface 
“I remember staring at it saying, “Where do I put the information 
in?” So it wasn’t as user friendly for data input” PCP10 (22yrs.) 
S4: Barrier 
Diagnosis: 
expand 
differential 
“I did, on a few occasions have no idea what I was looking at in a 
patient, and used [VisualDx]…to figure it out” PCP08 (3 yrs.) 
S5: 
Facilitator 
(Benefit) 
Diagnosis: 
confirm 
“I can definitely say it helped me feel more confident about a 
diagnosis.” PCP02 (32 yrs.) 
S5: 
Facilitator 
(Benefit) 
Usefulness: 
Irrelevance 
“If you put basal cell carcinoma in VisualDx, it’s a thousand 
pictures of every possible way it can show up. It’s not showing the 
typical ones” PCP03 (34 yrs.) 
S5 Barrier 
Patient 
communication 
“I used it with patients, especially if they had something that went 
away; then they could say,” Oh, it did look like that”. Helpful for 
patient communication? Absolutely.” PCP04 (17 yrs.)  
S6 
(Facilitator) 
Benefit 
Patient 
agreement 
“I would open it up in the patient room oftentimes, and go through it 
[all] with them.” PCP06 (4yrs.) 
S6 
(Facilitator) 
Benefit 
Usefulness: No 
Difference 
I can't think of a particular instance where it clinched it for me or 
made a clinical decision distinction or difference. It was more of a 
tool that I used to augment whatever I was looking into.” PCP09 (4 
yrs.) 
S5, S6 
Barrier 
 
 
